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Abstract 
Spider silk is one of nature's most promising biomaterial s for a variety of applications, however, due to 
the inability to fann spiders , transgenic hosts are required for large-scale production . With the unique 
combination of strength, elasticity , and biocompatibility, sp ider s ilk has an incredible potential for use in 
the human body. This study was conducted to merge two major applications of spider s ilk for the creation 
of a novel bandaging product. Electrospinning technology was utiliz ed to create a spide r silk/polym er 
bandage matrix to be applied with an aqueous spider silk skin adhesive. 
In designing the bandaging matrix , the mechanical properties of the electrospun si lk were evaluated 
against commercially-available product s and known values of human skin. The chosen formulation had 
phys ica l properties more comparable human skin than commercially-available products. The aqueous 
adhesive was tested in conjunction with the electro spun matrix for its adhesion and found comparable to 
commercial product s. The durability of the bandage was tested via cyclic stresses and found analogous to 
commercial products. The common antimicrobial chlorhexidine was incorporated into the adhesive and 
had a release profile lasting about 4 day s. With this incorporation into the aqueous adhesive, the adhesive 
can be reapplied to provide additional antimicrobial protection, a necessity in the healthcare industry. The 
bandaging showed no signs of inhibiting mammalian cell proliferati on under cytotoxicity testing. 
The final product, deemed "SpiderSkin," presents a unique bandaging solution capable of providing a 
healthy environment for the regeneration of epidermal tissue, while protecting the wound from outside 
infection , and providing mechanical stabi lity similar to that of human skin. 
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Project Summary 
The purpo se of this project was to create a bandaging produ ct by harnessing the mechanical propert ies of 
recombinant spider silk protein s (rSSps). Using an electrospinning device , the goal was to create an 
rSSps /polymer bandage matrix made of nanofiber s that can be incorporated with an aqueous rSSps skin 
adhesive to create an ultra-thin "secon d skin" to act as a barrier of defense in the event of a skin injury . 
Furthermore , thi s bandage may promot e healing by the elution of antimicrobials, growth factors, and 
other healing agents, while takin g advantage of the biocompatibility of the rSSps. This product will be 
mechanically sound under varied mechanical manipulation as well as under different environmental 
conditions. The resulting electrospun bandage matrix and adhesive will allow for an innovative product to 
both protect and heal numerous skin injurie s and will reduce the need for hospital staff to constantly 
change dress ings (a painful proce ss) since the components of this product will eventually degrade over 
time or simply peel off. Finally, the design of this product will provide a starting point for numerou s 
future projects including the possibility for a mechanically-stable cell scaffold to regenerate a patient 's 
skin in the event of major injury . The final product was named "SpiderSkin". 
Introduction 
The human body 's fir st layer of protection against the elements, disease, and regulation of internal 
processes is the skin. To provide effective protection , the skin must be able to regenerate as quickly as it 
is damaged. Unfortunately, in cases of extreme injuries, such as burns or large abrasions, or cases of 
decreased blood flow, as in pressure wounds, natural repair mechani sms prove insufficient. These injuries 
are both widespread and costly. The American Bum association estimates over 486,000 burn injurie s 
were treated in US burn centers in 2015 ("American Burn Association," n.d.). Approximately 2.5 million 
people are affected by pressure sores each year of which 159,000 are nursing home resident s ("American 
Burn Association"). 
In the above circumstances where extensive damage to the skin occurs, an extra layer of defense , 
effectively a second layer of skin, is needed to maintain the health and wellness of affected individuals. 
This "seco nd skin" must have similar prope1ties to that of the original: permeability , flexibility, and 
protection aga inst infection. The product may also serve as a scaffold for re-epithelialization. 
The purpo se of this study was to develop a seco nd skin capable of providing the environment nece ssary 
for natural repair while protecting the skin from further damage. The product was evaluated through 
te sting of mechanical prope1ties and cellular interaction s. 
Significance and Innovation 
Bandages protect wounds and promote healing by creating a moist environment that allows for natural 
repair without significant disruption. Problem s in the wound care industry today are numerous , and there 
have been many effo1ts to combat the se . The main problem s that this study sought to solve are: the 
occurrence of skin maceration and contact dermatitis in the skin surrounding the wound (made worse by 
continual dress ing changes), the ability to tune a bandage as the wound environment and needs change, 
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and com batting the risk of infection in immunocompromi sed patients. The goal of this project was to 
create a bandaging proce ss that will decrease the healing time and sca rring of wounds like bed sores or 
burns, without increa sing the damage to the skin during dressing changes and wound treatment. 
Objectives 
The main objective of this project is to create an rSSps electrospun "seco nd skin" with an rSSps-based 
adhesive that has the ability to match or surpass the properties of skin, while being comparable to the 
mechanical prope11ies of commercial product s. Fu11hermore, this product will promote hea ling through 
the elution of antimicrobials. The following are specific objectives related to the electrospun mat , 
adhesive, and the mat adhesive complex: 
• Use glutaraldehyde as a cross-linking agent to increase the mechanical properties of the adhesive. 
• Ens ure that the bandage (with and without glutaraldehyde) does not exhibit cytotoxicity. 
• Create a mat/adhesive complex with and without cross-linking that stretc hes without removal in 
cyclic flexion on pigskin. 
• Create a mat/adhesive complex with and without cross-linking that can be manipulat ed without 
removal in cyclic compression on pigskin. 
• Create an rSSps antimicrobial adhesive using chlorhexidine and exhibit a release of the drug over 
time. 
• Design a mat/adhesive complex that adheres to the skin as well as or better than commercial skin 
adhesives. 
Evaluation Criteria 
This project will be evaluated based on the following criteria: 
• Test different electrospun mat formulations using different concentrations and combinations of 
rSSps. Test the workability of these mat combinations by evaluating spinning effectiveness, 
material availability, and a pressu re-sensitive tape test. 
• Evaluate rSSps adhesives with and without cross-linking by including these two groups in eve1y 
mechanical adhesion test as well as an MTS tensile test for each complex. 
• Perform SEM imaging to observe the interaction between mat/adhesive to form a complex. 
• Perform cytotoxicity testing using both sets of adhesives (with and without glutaraldehyde). 
• Complete cyclic MTS fatigue testing with the banda ges inflexion under wet, dry , and humid 
conditions. Use a modified ASTM adhesion scale to evaluate results. Compare to contro ls 
Tegadenn and water-proof Band-Aids. 
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• Complete cyclic MTS testing with the bandage folding in compression under wet, dry, and humid 
conditions. Use a modified ASTM adhesion scale to evaluate results. Compare to controls 
Tegaderm and water-proof Band-Aids. 
• Compare the mechanical properties of the bandaging product with literature on mechanical 
prope1ties of human skin. 
• Test the bandage ' s ability to elute chlorhexidine while completely immersed in phosphate-
buffered saline solution with and without a cross-linked adhesive. UPLC analysis will be used to 
quantify the release kinetics. 
• Complete MTS T-Peel adhesion testing with the rSSps bandages, Tegaderm , and water-proof 
Band-Aids. 
Background 
Injuries to the skin occur by various modes and severities. Two major market s in which bandaging 
improvements are needed include burns and pressure wounds (bedsore s). This study was conducted in 
order to address specific needs for the treatment of burns , pressure wounds, and other serious health-
threatening epithelial injuries. 
Target Properties for Epithelial Wound Bandage 
Epithelial wounds can be difficult to treat and therefore bandages targeted for these wounds must be 
capable of meeting several requirements. Among the most impmtant prope1ties to consider are moisture 
control, oxygen transfer, antimicrobial effect , biocompatibility, and mechanical attributes. The need for 
moisture control can vary by wound type and severity. The ability of a bandage to absorb secretions of the 
wound without causing excessive dryness is ideal. Oxygen transfer into the wound is also necessary for 
proper healing mechanisms to occur, and thus it would be required for the bandage to be semi-permeable. 
With a semi-permeable bandage , the risk of infection is heightened , and thus bandages must inhibit 
bacterial infection. The most efficient bandages would also assist in the proliferation of epithelial cells 
and act as a scaffold to facilitate cell regeneration. The mechanical properties of an ideal bandage would 
closely mirror that of natural skin. 
Pressure Sores and Bums 
Pressure sores are one of the fastest growing problems among nursing home residents in the U.S. ln a 
2004 study it was found that more than 1 in 10 nursing home residents had a pressure ulcer (Lee, Jeong, 
Kang, Lee, & Park, 2009). This number will continue to increase as the baby-boomer generation reaches 
retirement age and the nursing home population grow s. This will result in a significant financial burden 
on the health care community and taxpayers. The annual cost for pressure ulcer management was $11 
billion in 2006 (Moore & Cowman , 2013). Jointly , the need for effective treatment of pressure sores is 
going to increase. 
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Figure 1. Pressure Wound Stages . 
Figure 1 illustrates common areas for pressure wounds to develop. The affected areas are often under 
constant pressure from bedridden patients. Pressure wounds are most easily managed in Stages 1 and 2 
before the wound penetrate s to the underlying musculature and bone as in Stages 3 and 4. 
Treatment of pressure sores often proves to be very difficult. It is necessary to maintain a healthy 
moisture balance in the wound. Wounds that release excessive moisture must be capable of drainin g the 
excess fluid, and dry wounds must produce a great enough barrier to reta in needed moisture (O'Nei l, 
2004). With bed sores in particular it is important that the bandage is gentle on the surrounding skin to 
prevent maceration of the skin. As with any wound that breaches the ski n, it is important to ensure that 
the wound does not become infected (Moore & Cow man, 2013). For this reason, antimicrobial bandages 
are the most advantageous. Finally , the cost of the bandage and how often it need s to be changed are 
important considerations for the patient and the medical industry . 
The American Burn Association has estimated that 486,000 people per year receiv e treatment for burns at 
hospitals /bum centers. Costs associated with the se burns total approximately $7 .5 billion ("American 
Burn Association," n.d.). Burn treatment is difficult as contact with bum wounds is very painful. 
Bandaging must be able to cover a large surface area, protect against nosocomial infection , and provide 
an environment that facilitates cellular proliferation (Rowan et al., 2015). To prevent painful removal of 
the wound dressing, having a bandage that slowly degrade s with time wou ld also be an immense benefit 
to the patient. 
Electrospun Bandages 
Electrospinning is a process by which polar polymeric so lutions (called dopes) are used to create 
nanofiber mats via high voltage application (Figure 2). Electrospinning began in 1934 and allowed the 
production of nanofibers using a high electoral charge from a syr inge needle to a collector plate or drum. 
The ability to produce mats made up of fibers on the nanosca le offer a number of desirable properties. 
First is the high surface area of bandage s produced by electrospinning . This can be key in encouraging 
hemostas is which can be vital to critical wounds (Karami, Rezaeian , Zahedi, & Abdollahi , 2013). This 
surfa ce area to vo lume ratio also means that the bandages can be extremely absorptive. In the healing 
proce ss, the body extrude s many liquids and the ability of a banda ge to absorb this assists recovery. As 
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discus sed earlier, bandages that allow a wound to breathe are more effective. Electrospun bandage s are 
semi-permeable which mean s the wound will not dry up, but will also not be vulnerable to further 
bacterial infection. The fine fiber size of electrospinning also allows electrospun bandages to contour to 
any type of wound. The better a bandage can conform to a wound the more effective it will be and this 
could be achieved in a numb er of ways with electro spun bandages. For example, pre-spun bandage s could 
contour well due to their fine fiber size or bandage s could be electrospun directl y onto a wound to achieve 
nearl y perfect conformation. An electro spun bandage can use a wide variety of polymers and be loaded 
with substances such as antimicrobials and growth factors. Electrospun bandage s also can easily be made 
bioactive by incorporating drugs into the fiber s. Last ly, the bandage s can act as a scaffo lding which 
assists skin and veins in regrowth , leading to less scarring. 
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Figure 2. Illustrat ion of electros pinning concepts. 
Different polymers (specifically rSSp s) will be used to design several applications for wound covering. 
Spider silk made up of biocompatible protein s known for their elasticity and strength (Lewis, 2006; 
Panilaiti s et al., 2003). By using combinations of polymers, the physical characteristics of the bandage 
can be modified for specific applications /areas of the body. Dopes can be loaded with compound s before 
being electrospun. The effectiveness of antimicrobial therap y will be explored when loaded into the 
rSSps /polymer dope s. 
Potential Applications of rSSps Bandage Material s 
As a biopolymer , spider silk pre sents unique characteristics as compared to leading therapies. Spider silk 
is bioc ompatible and thus will not interfere with natural healing processes( Lewis, 2006). Antimicrobial 
compounds and growth factors can be incorporated into the electro spun bandage and/or adhesive to 
provide protection against infection and induce cellular regrowt h. Moisture control can be managed by 
varying the thickne ss of the bandage as well as the amount of adhesive applied. 
Mechanical properties of rSSps are such that the applied bandage would withstand continued stress 
without failure. rSSps can be used as both the bandage material as an electrospun mat, and as the adhesive 
to bind the mat to the wound. Electrospinning produce s fiber s in the nano- sca le, enabling small 
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molecules, such as oxygen , to pass through with little res istance . Because of the high surface-area-to-
volume ratio of nanofibers , bandage s functionalized with antimicrobial compounds or growth factors will 
release quickly and efficiently into the wound (Maleki, Latifi , Amani-Tehran , & Mathur, 2013). 
Current Epithelial Wound Treatment 
Currently, there are two main classes of bandage s. Pass ive bandage s see k to cover a wound to allow the 
body to heal and recover underneath. They do little to help the body but prevent further infection of 
injury. A commonly used example is gauze . Pas sive bandage s can inhibit healing because they do not 
allow air into the wound which can cause the wound to dry up . Bioactive bandages, on the other hand, 
seek to not only cover a wound but to allow it to breathe. They are more porous and allow water vapor 
and oxyge n to the wound site which can help healing. Biological compounds can also be incorporated to 
affect the chemical environment of the body and help it to heal. rSSps electrospun bandages would be 
bioactive bandages which competes with current bandaging options. 
Tegaderm is a commonly used product for pressure sores. This bandage boa sts a number of advantageous 
propertie s. It is clear which enables the user to observe the wound without having to remove the bandage 
repeatedly. It is water and oxygen permeable allowing the wound to " breathe " naturally . The bandage 
prevent s bacterial contamination into the wound but doe s not have any propertie s to treat existing 
bacterial infection. However , Tegadenn chlorhexidine gluconate (CHG) bandag es have been shown to 
exhibit antibacterial prope11ies. 
Literature Review 
Electrospun Bandaging for Wound Therapy 
Wound dressing s have significant potential for improvement as technologie s advance in fabrication 
methods and available materials. Dre ssi ngs have developed from natural material s designed for bio-
inertness and have advanced to bioactive states, improving the healing proce ss beyond the body's natural 
capabilities. Key players in this progre ss ion have been fabrication via electrospinning and the 
incorporation of anti-microbial and anti-inflammatory agents. The purpo se of the se newer dre ssings is to 
control the biochemical states of the wound. 
In 2010 Zahedi et al. publi shed a review on wound dressing s with an empha sis on electrospun polymeric 
bandage s (Zahedi, Rezae ian, Ranaei-Siadat, Jafari, & Supaphol, 20 I 0). In this review, a large variety of 
polymeric compounds, such as alginates, cellulose, chitin, and hyaluronic acid have been extensively 
studied. A challenge with many of these polymers is their limited solubility (Lee et al., 2009). 
From the studies in the above reviews , only a small variety of antimicrobial additives were used , the most 
common being ionic silver. The review found the release rate of the antimicrobials to be of supreme 
imp011ance as the large surface area of electrospun fibrous mat s causes an initial burst of antimicrobial 
release followed by a severely lessened steady release rate (Zahedi et al. , 20 I 0). In order to combat the 
initial burst , one group electrospun core-shell nano fibers with the antimicrobial compound inside of the 
polym er to reduce the initial burst. This method effectively reduced the initial burst release rate (Maleki et 
al. , 2013) . 
6 
Ln a novel study published in 2012, Arenbergerova et al. produced a nanofiber textile doped with a 
tetraphenylporphyrin (TPP) photosensitizer. When this compound is activated by visible light, it releases 
a reactive oxygen compound that inactivates bacteria at the surface (Arenbergerova, Arenberger, Bednar, 
Kubat, & Mosinger , 2012). 
Several groups began experimenting with alternative biomaterials for preventing infection. In 2012 
Karami et al. introduced thymol , an extract from thyme, into poly(e-caprolactone) (PCL), poly(lactic 
acid) (PLA) electrospun mats. The group found thymol effective against both gram-positive and gram-
negative strains of bacteria. Wounds treated with thymol had a closure rate of 92.5% after 14 days 
(Karami et al., 20 I 3). 
Ln 2015 a novel aspect of bandaging was introduced with the use of zwitterionic nanofibers created to 
reduce cell adhesion to the dressing. Through their poly ( carboxybetaine-co-methyl methacrylate) 
copolymer, the group demonstrated that blood cells did not attach to the membrane and thus would not 
cause clotting at the wound site (U nnithan et al., 2016). 
Recent studies have had a large focus on anti-microbial additives, as anti-bacterial resistance and 
nosocomial infection is becoming an ever greater issue in treatment. The other main area of focus is using 
polymers that will have favorable reactions with living tissue. Arenbergerova presented a novel anti-
microbial product; however , a light requirement could be problematic in situations where the patient has 
limited mobility or the wound is in a hard-to-reach area. 
Incorporation of naturally-occurring compounds such as thymol is an area with many possibilities and 
potential for findings that could vastly improve current technologies in the medical field. Further research 
should be done using biopolymers in combination with natural anti-microbial compounds for finding 
effective methods of protecting the wound from infection and inducing healing mechanisms. This study 's 
focus was to understand the interaction between electrospun rSSps mats /adhesives alongside the release 
kinetics of antimicrobial/growth-inducing compounds. 
Spider Silk as a Biomaterial 
Recombinant spider silk proteins have captured the attention of researchers for many years now. These 
highly conserved protein sequences have endured millions of years of evolutionary pressure and , 
depending on the species, have uses ranging from prey capture to egg sac formation (Lewis, 2006). The 
most notable and highly sought after silks are the major ampullate silks also known as dragline silk. As 
nature's strongest biomaterial, dragline silk is tougher than Kevlar and stronger than steel by weight. This 
remarkable combination of strength and elasticity has ignited numerous research projects to produce large 
quantities of these proteins in transgenic hosts. The hurdles associated with this are the large size of the 
native proteins (>250kDa) , purification and solvation of these proteins , and expression of these proteins 
in transgenic hosts without truncation (Xia et al., 2010). Once produced, these naturally insoluble 
proteins have been solvated using harsh organic solvents. However, using high heat and pressure it was 
found that rSSps could be solvated in water, opening the door to a wide variety of biomedical applications 
(Rising, Widhe, Johansson , & Hedhammar, 2011). 
Spider silk's impressive mechanical prope11ies have yielded a lot of interest in the production of synthetic 
spider silk fibers. Beyond fibers alone, it has been found that spider silks can be used to produce a wide 
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array of materials such as fibrous mats, adhesives, coatings, films , hydrogel s, lyogels, and sponges (Jones 
et al., 2015). The lack of an immun e response with respect to spider silk proteins has also led to numerous 
research projects using silk products as cell scaffolding (Bauer, Wohlrab , & Scheibe), 2013). These 
scaffolds allow for cells to attach and differentiate on a matrix that can then be transferred to a living 
system. 
Current Bandaging Hurdles and Research Associated with Epidermal Recovery 
With new advances in biotechnology and biomaterials, research into wound healing and bandage s is 
rapidly increasing . Normal bandages cannot provide the ideal conditions for wounds to heal properly , and 
even contribute to conditions in which a wound could be further damaged. Current effmts include probe s 
and sensors to manipulate the conditions of wounds dressed in conventional bandages (Mone, 2015). 
One study showed the antimicrobial effects of chitosan acetate bandages on mice with burn wounds. 
Although the bandages reduced inflammation , they also stuck to the wounds (Burkatovskaya, Castano, 
Demidova-Rice , Tegos, & Hamblin, 2008). The consequence of a bandage that cannot be easily removed 
is that the wound could be fu1ther damaged and the overall healing process could take longer (Mone, 
2015). 
Electrospun mats are currently being considered for use in the treatment of large wounds. The wounds 
can heal relatively quickl y if covered in electrospun materials. The porous materials created from 
electrospinning method s provide excellent barriers between the outside environment and the wounds they 
are covering. They allow for gases to pass through , such as oxygen, but have sma ll enough pores to 
prevent bacteria from passing (Wendorff, Agarwal, & Greiner, 2012). 
Bandages typically involve some so1t of adhesive, and their ability to stick and be removed from the skin 
can have a big impact on consumer's perception of the product s. However , the actual adhesive being used 
is often overlooked in the design process. The future of smart bandages depends on the combination of 
bandage and adhesive research ("Pressure-Sensitive Medical Technology"). 
Medical products, such as adhesives, must go through biocompatibility assessments to be approved for 
human use. Researc hers in India cured polyurethane pressure-sen sitive adhesive tape by electron beam 
and followed ISO guidelines to determine if their method produced a biocompatible product (Singh). 
The aim of this project is to create a product prototype which combines innovative materials in bandages 
and adhesives to create a "seco nd layer of skin" which promotes wound healing , protects against 
microbial infection, and can be absorbed by the body. The bandaging system will be sp ider silk based, 
making it more biocompatible than bandaging systems made from synthetic materials. A nylon-spider 
silk electrospun mat is to be used in combination with a spider silk adhesive, either of which can be 
loaded with antimicrobials and various growth factors to further promote healing. 
Silk Products used in Epidermal Recovery 
The use of silk polymer s for wound treatment has existed for thousands of years. However , toda y, much 
research is being done to test the efficiency of these polymers as a biocompatible treatment. Some of the 
advantages of using spider silk are argued to be its ability to be resorbed into the body and to not illicit an 
immune response from the host. The largest challenge in creating a viable spider silk bandage is the 
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ability to mass produce the spider silk protein and subsequently, spider silk thread and non-fibrous rSSps 
products. This review will identify what work has been done and how it can be applied to the use of 
electrospun spider silk as a viable wound treatment. A11icles will be reviewed for their application to this 
project, supporting evidence, and scope of research. 
The toxicity of silk proteins in epidermal applications is impo11ant and within the scope of this study to 
explore. The topical application of a silk protein film has been used to test dermal irritation in rats and 
hamsters using the Draize test (Padol et al., 2011 ). This a11icle offers a good animal testing scenario to 
show that silk protein films are non-toxic when applied to the skin. On the other hand, it has too broad of 
a scope in that the type of silk protein used is not clearly identified. It would be most valuable if spider 
silk were the type used. The applications were all on healthy test subjects, not on those with any so11 of 
wounds. It would be valuable to see the dermal response in a compromised area, such as a burn. 
Studies have also been done to test the ability of spider silk fibers to serve as a scaffold for skin cell 
culture. An a11icle by Wendt tested this possible application. This articles strengths came in using spider 
silk fibers and testing skin culture regrowth, both of which would be valuable to the topic . However , the 
at1icle uses a very simplistic model with limited replication or statistical analysis. The results show 
potential for the application but miss the mark of offering definitive evidence (Wendt et al., 2011 ). 
The applications of spider silk as a biomaterial has also been studies. An article by Vepari offers the most 
extensive research and results. It is beneficial in showing past studies where silk has been used for tissue 
scaffold applications. However, similar to the Padol article, the scope of this article may be too broad. It 
uses a variety of silks and a variety of forms of the silk , rather than simply fibers or electrospun mats 
(Vepari & Kaplan , 2007). 
From this review, it can be dete1mined that spider silk offers a novel biomaterial in te1ms of its strength 
and biocompatibility. However, there are still many areas which need to be researched. These articles 
show that spider silk can be used without causing harm to the host and even encourage epidermal cell 
regrowth. But the research lacks information regarding the use of electrospun spider silk and its potential 
as a tissue scaffold. Also, no a11icle shows the effects of glutaraldehyde as a cross linking agent and the 
potential toxicity associated with that treatment. Both of these would be valuable areas for fu11her study. 
Design Process 
A. Overview 
The design process for this project was orchestrated with mechanical prope11ies, functionalization 
prope11ies, and biocompatibility in mind. The different tests were designed to evaluate the mechanical 
properties of the electrospun bandages as well as providing proof of concept for antimicrobial elution. 
Because glutaraldehyde was used as a cross-linking agent in the fonnation of some of the electrospun 
bandages, development of a cytotoxicity test was also necessary to evaluate the product's effectiveness 
when exposed to living cells. 
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Figure 3 shows the current concept map of ideas for this project. As the design progress continues , the 
concept map will adapt to illustrate the decision making and the ideas that were pursued throughout this 
project. 
T-Peel 
Mol-Sjny 
Tenue 
AgNPs 
Spider Skin 
Or,lo sian 
nylon m4 
BSA/Glutarnldehyde 
Figure 3. Design process concept map showing the different ideas and methods of testing that were 
explored in this study. 
B . All Materials 
• Goat-derived recombinant spider silk protein s (rSSps): major ampullate spidroin I (rMaSpl) and 
major ampullate spidroin 2 (rMaSp2) 
• 97% Formic Acid 
• Distilled water 
• Pigskin 
• Electrospinner 
• MTS (Mechanical Testing System) Synergie I 00 
• MTS Cards (8 mm gage distance) 
• Optical Microscope 
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• Digital Camera 
• Motic Imaging Software 
• Test Works 4 Software 
• Sprayer 
• Humidifier 
• UPLC Chromatographic System 
• End-over-end plate mixer 
• Centrifugal Dryer 
• 8 mL screw cap tubes with a flat base 
• Nunclon 24 we ll plate s 
• MRC-5 Lung cells 
• DMEM + I O¾FBS media 
• 50% glutaraldehyde in solution 
• Tryp sin 
• ViCell 
C. Selection of Mat/rSSps Adhesive Formulation 
Rationale 
Initial tests were chosen to decide what was the best formulation of electrospun mat and rSSps adhesive 
to use for the continuation of the project. The following factors were evaluated: ease of spinning, material 
availability, best adhesive prope1ties when combined with the electrospun mat. 
Decisions 
This initial thought process led to the decision to test the remaining three mat formu lations using the 
criteria of ease of spinning, material availability, and performance using the on-skin pressure sensitive 
tape test. 
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Mat Formulation 
Nylon Nylon/rMaSpl Nylon/rMaSpl/rMaSp2 
Eliminated Before Testing 
Figure 4. Decision tree for rSSps mat/adhesive formulation 
Materials 
20% Nylon dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
10% Nylon + 10% rMaSp 1 dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rMaSpl 
I 0% Nylon I 0% rSSps 80/20 rMaSp l/rMaSp2 dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.24 g rMaSpl (rSSps protein) 
• 0.06 g rMaSp2 (rSSps protein) 
Other polymers 
Pros: opportunites for 
biodegradability/better 
mechanical properties 
Cons: not enough time to 
thoroughly test all polymer 
options 
j 
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12% 50/50 rMaSpl/rMaSp2 rSSps adhesive: 
• 3 mL distilled water 
• 0.18grMaSpl 
• 0.18 g rMaSp2 
12% 50/50 rMaSp I /rMaSp2 + 1 % Glutaraldehyde rSSps adhesive: 
• I mL 12% 50/50 rMaSpl/rMaSp2 rSSps adhesive 
• 20 µI 50% glutaraldehyde stock 
12% 50/50 rMaSpl/rMaSp2 + 1% Glutaraldehyde + 10% Bovine Serum Albumin rSSps adhe sive: 
• I mL 12% 50/50 rMaSp l/rMaSp2 rSSps adhesive 
• 20 µI 50% glutaraldehyde stock 
• 0. lg 96% bovine serum albumin lyophilized powder 
Methods 
Mat formulation: 
For this test there were 3 different initial mat formulations tested: 20% nylon , I 0% nylon I 0% rMaSp I 
protein, and 10% nylon 10% 80/20 rMaSpl /rMasp2 proteins, all of which were dissolved in formic acid . 
The method for dope preparation as well as the spinning protocol is explained in detail in Appendix A. 
Three spins (I ml dopes for each spin) were completed for each of these formulations and were monitored 
for ease of spinning. The criteria for this was : the thickness of the mat created , how well the mat could be 
manipulated by hand without falling apart, and how many drops were created from the dope solution 
during the spin that altered the effectiveness of the final mat. Availability of materials wa s also 
considered during this test. 
Adhe sive formulation: 
There were 3 different initial adhesive formulations tested: 12% 50/50 rMaSpl/rMaSp2 rSSps adhesive , 
12% 50/50 rMaSpl/rMaSp2 + 1% Glutaraldehyde adhesive, 12% 50/50 rMaSpl/rMaSp2 + 1% 
Glutaraldehyde + 10% bovine serum albumin adhesive. The method for the adhesive preparation is 
further explained in Appendix A. The ease of production and application of each adhesive formulation , in 
combination with each mat formulation was the initial criteria in deciding which adhe sive to use. 
Pressure-sensitive tape test: 
Thi s test wa s conducted to narrow the choices for the mat and rSSps adhesive. The methods for this test 
were derived from ASTM 03359-09 . Fresh pigskin was cleaned and shaved as detailed in Appendix C 
and electro spun mats were prepared according to the protocols in Appendix A. The rSSps adhesives were 
prepared in three different formulation s: 50/50 rMaSpl :rMaSp2, 50/50 rMaSpl :rMaSp2 with I% 
glutarald ehyde , and 50/50 rMaSp I :rMaSp2 with I 0% bovin e serum albumin (BSA) . Different ratio s of 
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rMaSp 1 and rMaSp2 were not explored because previous research has shown these goat-derived rSSps 
adhesives constitute the best mechanical properties (Jones et al., 2015). The different electrospun mats 
were cut into 5 cm x 2.5 cm rectangular samples. Five samples of each of the three mats were applied and 
adhered to the fresh pigskin with each of the three rSSps adhesives and left to dry for approximately 35 
minutes. Once the mats were dry , 1 cm X-shaped incisions were made to the mats and covered in small 
pieces of painting tape. The tape was peeled off from the mat and results were based on a 0-5 sca le as 
follows: 
Table 1. Pressure-Sensitive Tape Test Grading Scale 
SA No peeling or removal 
4A Trace peeling or removal along incisions or at their intersection 
3A Jagged removal along incisions up to 1.6 mm on either side 
2A Jagged removal along most of incisions up to 3 .2 mm on either side 
IA Removal from most of the area of the X under the tape 
OA Removal beyond the area of the X 
Scanning Electron Microscopy: 
SEM imaging was used to evaluate the surface conditions of the electrospun mat/rSSp s adhesive 
complex. The qualitative analysis of the bandage material was to see the adhesive /mat matrix and how the 
adhesive permeated the fibers. This was one of the first steps in the initial characterization of the 
bandaging product. 
Results 
The SEM images indicated that there was an infiltration of the rSSps adhesive into the fibrous pores of 
the electrospun mat, causing it to change from a white material with no transparency to a material with 
complete transparency. This imaging was the first step in the characterization of the bandaging product. 
No major difference was seen in the su1face characteristics of the different materials, however it became 
clear that the adhesive saturated the surface to the point that the individual fibers were no longer visible 
(Figure 5). 
Table 1 illustrates how the different mat/rSSp s adhesive combinations performed for the three criteria: 
ease of electrospinning, material /protein availability , and the pressure-sensitive tape test performance. All 
were analyzed on a 0-5 sca le. The pressure-sensitive tape test scale is shown above and the numbers 
reported below are an average score with n=5. From these results, it was decided to move forward with 
the rest of the study using a 10% Nylon: 10% rMaSp I mat due to the fact that it was relatively easy to 
spin and interacted better than the other two mats with the rSSps adhesive s. As for the rSSp s adhesives , 
the rest of the study moved forward using two adhesives: the 50/50 rMaSp I :rMaSp2 adhesive and this 
same adhesive with I% glutaraldehyde added as a cross-linking agent. It was noted during these 
experiments that the 1 % glutaraldehyde adhesive was easier to work with than the other adhesives and it 
was given a good score on the pressure-sensitive tape test s. It was decided that this cross -linking agent 
was of interest in this study, therefore all future study includes an analysis of both these adhesives. 
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Table 2. Criteria Comparisons for Mat/rSSps Adhesive 
Criteria Weight a 20% Nylon Mat 10% Nylon / 10% 10% Ny lon/ I 0% 
rMaSpl 50/50 
rMaSp 1 :rMaSp2 
50/50 Spinning: 0.3 Spinning: 5 Spinning: 4 Spinning : 3 
rMaSp I :rMaSp2 Availability: 4 Availability : 4 Availabi lity: 2 
Adhesive Tape Test: 3 Pressure- sensitive Pressure-sensitive 
TOTAL: 3.9 Tape Test: 4.5 Tape Test: 4 
TOTAL: 4.2 TOTAL: 3.1 
50/50 Availability : 0.3 Spinning: 5 Spinning: 4 Spinning: 3 
rMaSp 1 :rMaSp2 Avai lability: 4 Availability: 4 Availability: 2 
Adhesive w/ I% Tape Test: 3 Pressure-sensitive Pressure-sensitive 
glutaraldehyde TOTAL: 3.9 Tape Test: 5 Tape Test: 4 
TOTAL: 4.4 TOTAL: 3.1 
50/50 Tape Test: 0.4 Spinning: 5 Spinning: 4 Spinning: 3 
rMaSp 1 :rMaSp2 Availability: 4 Availability: 4 Availability: 2 
Adhesive w/ 10% Tape Test: 1 Tape Test: I Tape Test: I 
BSA TOTAL: 3.1 TOTAL: 2.8 TOTAL: 1.9 
.. 
a. Ease of sp111n111g, ava1lab1lity of material, and the pressure-sens1t1ve tape test were given weights of importance of 30%, 30%, and 40% 
respectively. 
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Figure 5. SEM images at 5000x magnification. (A) Nylon-rMaSp I electrospun mat with 50/50 
rMaSpl :rMaSp2 adhesive , (B) Nylon-rMaSp2 mat control with no adhesive 
Conclusion 
By doing a criteria comparison test using the criteria: ease of spinning, material availability , and the 
pressure sensitive tape test results it was possible to eliminate the mat fonnulations of 20% nylon , and 
I 0% 50/50 rMaSp I /rMaSp2 with 10% nylon. Using a combination of all of these criteria , the project was 
able to move forward with a mat formulation that performed well on skin, was easy to electrospin, and all 
materials for this formulation were readily available. Of course , much more research could be done to 
optimize this mat formulation, perhaps creating a mat that is made of only rSSps or including polymers 
that have different levels of biodegradability and testing how these polymers interact with the rSSps. 
The SEM imaging allowed for the qualitative analysis of the bandaging product and allowed for a visual 
representation of the interaction between the nanofibers of the electrospun mat and the rSSps adhesive. 
The adhesive covers and encompasses these nanofibers as was hypothesized. 
D. T-Peel Testing 
Rationale 
T-peel testing was conducted to test the strength of the adhesives compared to already existing medical 
adhesives. This test was derived from ASTM F2256. Water-proof Band-Aids and Tegaderm tape were 
used as controls for comparison. Only the clear adhesive portions of these control bandages were used so 
that a direct adhesive comparison was possible. 
Decisions 
Due to the fact that this was the first on-skin quantitative test the decisions made during this testing period 
were carried through for the remainder of the design process. Therefore, the same controls and the same 
environmental testing conditions were carried out in all mechanical testing thereafter. 
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Figure 6. Decision Tree for T-Peel Testing. 
Materials 
• MTS (Mechanical Testing System) Synergie l 00 
• Humidifier 
• Distilled water 
• Water-proof Band-Aids 
• Tegagerm dressing 
• Pigskin 
• Sprayer 
l 0% Nylon + l 0% rMaSp l dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rMaSpl 
12% 50/50 rMaSp l/rMaSp2 rSSps adhesive: 
• 3 mL distilled water 
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• 0.18 g rMaSp 1 
• 0.18grMaSp2 
12% 50/50 rMaSp I /rMaS p2 + 1 % Glutaraldehyde rSSps adhesive: 
• 1 mL 12% 50/50 rMaSp l/rMaSp2 rSSps adhesive 
• 20 µI 50% glutaraldehyde stock 
Methods 
Strips of pigskin were prepared according to Appendix C so that one 0.5 cm x 2.5 cm electrospun mat or 
control strip fit on each strip of skin. Of the 60 mat strips glued onto the strips of pigskin , 30 were glued 
with the 50/50 rMaSp I :rMasp2 adhesive and 30 were glued with the rMaSp 1 :rMasp2 + I% 
glutaraldehyde adhesive. The properties of the adhesives were subjected to three different conditions: dry, 
humid, and wet. These conditions are provided in more detail in Appendix D. 
As seen in Figure 7 an edge of each mat or test control was pulled up from the skin to fit into the top MTS 
grips, while the skin was secured to the bottom grip. As the top grip moved up the bandage system was 
peeled off of the skin. The samples were pulled off at a rate of 2.5 mm/min, and the average load to peel 
the sample off of the skin was measured. This test was derived from ASTM F2256. 
Figure 7. Illustration of T-Peel Adhesive Testing. 
Results 
The maximum load recorded was compared between the groups in dry, humid, and wet conditions (Figure 
8). Stati stical analysi s was performed via JMP® software. The visual outputs of JMP® are explained in 
Appendix F. 
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The rSSps adhesives with and without glutaraldehyde were shown to have an adhesive strength between 
that of Tegaderm and Band-Aids. Band-Aids proved to have the greatest adhesion to the skin, while 
Tegaderm was con sistently one of the lowest. The rSSps samples showed no significant difference in 
adhe sive strength between the wet, dry, and humid conditions tested . However , the rSSps and 
glutaraldehyde adhesive sample s tested under dry and wet condition s exhibit ed higher adhesive strength 
than the rest of the samples , except for the Band-Aid samples tested under the same conditions. The 
sample s are arranged into statistically significant groups in Figure 9. 
. - . 
L1 Connecting letters Report 
Level 
BandAid Dry 
BandAidW et 
8andAid Humid 
ss~Glu Wet 
SS+Glu Dry 
SS Dry 
SSWet 
Tegaderm Wet 
SS+Glu Humid 
SS Humid 
Tegaderm Humid 
Tegadem1 Dry 
A 
A 
B 
B C 
B C D 
C D E 
D E 
E 
E 
E 
E 
E 
Mean 
0.79910950 
0.67611520 
0.45042420 
0.40291775 
0.34410333 
0.26340756 
0.22964380 
0.16771344 
0.15617375 
0.15597560 
0.13997490 
0.13303520 
Figure 9. Stati stical Grouping s of T-Peel test s 
Conclusion 
The rSSps and rSSps with glutaraldehyde adhesive sample s matched or exceeded the adhesive strength of 
commercially-available Tegaderm, but did not adequately compare to the Band-Aid sample s for this 
specific test. The results indicate that the rSSps adhesive s are capable of competing with commercial 
products in the adhesive realm. 
E. Cyclic Fatigue Testing with Bandages in Compression 
Rationale 
Cyclic fatigue te sting in compre ssion was conducted in order to evaluate the efficacy of the bandage 
under cyclic compres sion. This scenario would be seen in real-lif e application when the bandage is 
applied near or on joints . The ability of the bandaging material to stay intact and adhered onto the skin 
when compression lines are formed was considered vital for the stability of the product. 
20 
Decisions 
Design of test method 
Humid Conditions Wet Conditions Dry Conditions 
Figure 10. Decision tree for cyclic fatigue testing with bandages in compression. 
Materials 
• MTS (Mechanical Testing System) Synergie 100 
• Humidifier 
• Distilled water 
• Water-proof Band-Aids 
• Tegagerm dressing 
• Pigskin 
• MTS Cards (8 mm gage distance) 
• Sprayer 
I 0% Nylon + 10% rMaSp I dope : 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rMaSpl 
12% 50/50 rMaSp I /rMaSp 2 rSSps adhesive: 
21 
• 3 mL distilled water 
• 0.18grMaSpl 
• 0.18grMaSp2 
• 0.03 µI Glutaraldehyde (50% stock solution) 
• 0.1 g Bovine Serum Albumin (BSA) 
12% 50/50 rMaSp I /rMaSp2 + I% Glutaraldehyde rSSps adhesive : 
• I mL 12% 50/50 rMaSp 1/rMaSp2 rSSps adhesive 
• 20 µl 50% glutaraldehyde stock 
Methods 
Nylon /rMaSp 1 mats were cut into 0.5 cm x 2.5 cm strips and glued in group s of 3-4 unto prepared pieces 
of skin with the rSSps adhesives (with and without glutaraldehyde). Once dry, the piece s of skin were 
secured on the MTS by grips on the top and bottom sides, with the mats oriented upright (Figure 11). The 
MTS was programmed to move the top grip at a rate of 5 mm/sec up and down I 00 times bending the 
skin to about 90° to create cyclic stress, compressing the bandage . The testin g wa s conducted under three 
different conditions (wet, dry, humid) according to Appendix D. After the testing was completed the 
adhesion of the bandage material (either control bandange or electrospun mat formulation) were evaluated 
according to the sca le detailed in Table 3. The ratings were done by the same individual to avoid 
differences in rating style and personal preference. Statistical analysis was performed via JMP® softwa re. 
The visual outputs of JMP® are explained in Appendix F. 
Table 3. Cyclic fatigue in compression grading scale 
SA No peeling or removal 
4A Trace peeling or separati on from the substrate 
3A Half of the bandage is separated 
2A More than half of the bandage is separated 
lA Most of the bandage is separated 
OA Full separation 
22 
Figure 11. Illustration of compression cyclic testing using the MTS . 
Results 
Following statistical analysis, all variations of SpiderSkin (with and without glutaraldehyde) were in the 
same statistical grouping as the commercial bandage material Tegaderm. Furthennore, under this 
compressive testing , water-proof Band-Aids were significantly worse in wet conditions than all other 
groups due to the separation of the the bandage material as the compression lines were manipulated and 
moisture got underneath the bandage. 
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.o Connecting Letters Report 
Level Mean 
BandAid Dry A 4.9000000 
SS+Glu Dry A 4.9000000 
SS+Glu Wet A 4.9000000 
Tegaderm Wet A 4.9000000 
Tegaderm Dr; A 4.8000000 
SS+Glu Humid A 4.7000000 
SSDry A 4.6000000 
SS Humid A 4.6000000 
Tegaderm Humid A 4.5000000 
BandAid Humid A 4.3000000 
SS 'Net A 4.2000000 
BandAid Wet B 3.1000000 
levels not connected by same letter are significantly different. 
Figure 13. Connecting Letter s Repo1t for Compressive Fatigu e Testing 
Conclusion 
All groups pe1formed s imilarl y, with the exception of Band-Aid which had s ignificantl y reduced adhesion 
under cycl ic compression in wet condition s. Both glutaraldehyde and non-glutaraldehyde bandages were 
comparab le to commercially available product s . The rSSps adhe sives with and without glutaraldehyde 
exh ibited an ability to maintain adhesion of the nylon/rSSps mat under compression even in wet and 
humid conditions. 
F. Cyclic Fatigue Testing with Bandages in Flexion 
Rationale 
Th is test , similar to the cyclic fatigue testing in compression, will be used in evalu ating the efficacy of the 
bandage under repeated flexion. This will occur most intensely when the bandage is applied to a joint. 
25 
Decisions 
Design of test method-
flex bandage at same 
position 
Wet Conditions 
Figure 14. Decision tree for cyclic fatigue testing with bandages in flexion 
Materials 
• MTS (Mechanical Testing System) Synergie 100 
• Humidifier 
• Distilled water 
• Water-proof Band-Aids 
• Tegagerm dressing 
• Pigskin 
• MTS Cards (8 mm gage distance) 
• Sprayer 
I 0% Nylon + 10% rMaSp I dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rMaSp I 
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12% 50/50 rMaSp 1/rMaSp2 rSSps adhesive: 
• 3 mL distilled water 
• 0.18grMaSpl 
• 0.18grMaSp2 
• 0.03 µI Glutaraldehyde (50% stock so lution) 
• 0.1 g Bovine Serum Albumin (BSA) 
12% 50/50 rMaSp l/rMaSp2 + 1 % Glutaraldehyde rSSps adhesive: 
• 1 mL 12% 50/50 rMaSp l/rMaSp2 rSSps adhesive 
• 20 µI 50% glutaraldehyde stock 
Methods 
The nylon/rSSps electrospun mats were cut into 0.5 cm x 1.5 cm strips and two mats were applied to the 
center of square shaped pieces of pigskin with the rSSps , or rSSps + glutaraldehyde adhesives and left to 
dry. To set up the flexion test, each piece of skin was secured between two frames, screwed into place to 
prevent movement of the skin, and a rod with a rounded top was used to push the skin 10 mm upward . 
Figure 15 shows this setup. The thickness of these skin pieces averaged 13 mm. 
:u__ 
Figure 15. Flexion Testing (A) illustrates the flexion apparatus. (B) Illustrates the testing with the pigskin 
loaded in the apparatus. 
Results 
Grades were given to the bandages in dry , humid, and wet condition s (Figure 16). Statistical analysis was 
performed via JMP® software. The visual outputs of JMP® are explained in Appendix F. 
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In contrast to the compressive fatigue test detailed above, there was much more variation between groups 
in flexion fatigue testing. The rSSp s adhesive withstood fatigue testing similar to Band-Aid and exceeded 
the results ofTegaderm. The groups are further detailed in Figure 17. 
L1 Connecting Letters Report 
Level Mean 
SS Humid A 4.8000000 
BandAid Humid A B 4.6000000 
SS+Glu Humid A 8 4.5000000 
BandAid Dry A 8 4.4000000 
SSWet A 8 4.1428571 
SS Dry A B 4.0000000 
SS+Glu Dry A B C 3.4000000 
SS+Glu Wet 8 C 3.2000000 
Tegaderm Dry B C 3.2000000 
BandAid Wet C D 2.4000000 
Tegaderm Humid C D 2.0000000 
Tegaderm Wet D 1.6000000 
levels not connected by same letter are significantly different. 
Figure 17. Connecting letters repo1t for cyclic flexion testing. 
With the exception of the rSSps adhesive with glutaraldehyde as a cross-linker, the rSSps adhesive alone 
was not statistically diff erentiable from water-proof Band-Aid. The rSSps adhesive with glutaraldehyde in 
the wet condition was significantly different from Band-Aid in wet conditions, as well as matche s or 
exceeds Tegaderm and Band-Aid in every condition tested, respectively. 
Conclusion 
This test showed that the adhesive propertie s of both the rSSp s and the rSSps + glutaraldehyde bandages 
under dry, wet, and humid conditions were not affected to the same degree as the Band-Aid and 
Tegaderm. Although adhesive strength not increased with the addition of glutaraldehyde, the performance 
of the rSSps adhesive under wet and humid conditions suggests it would be a good alternative for 
dressing wound with very high moisture levels. 
G. Tensile Testing of Materials 
Rationale 
Ten sile testing was conducted to compare four basic mechanical propertie s: toughness, elastic modulu s, 
strain at failure, and ultimate tensile strength. The prope1ties of the electrospun mat with applied 
adhesives were compared to Tegaderm and water-proof Band-Aid, as those products contain similar 
mechanical prope1ties to those desired of the final product. 
29 
Decisions 
Testing Method 
Figure 18. Decision tree for tensile testing. 
Materials 
• MTS (Mechanical Testing System) Synergie 100 
• Humidifier 
• Distilled water 
• Water-proofBand-Aids 
• Tegage1m dressing 
• Pigskin 
• MTS Cards (8 mm gage distance) 
• Optical Microscope 
• Digital Camera 
• Motic Imaging Software 
• Test Works 4 Software 
• Sprayer 
I 0% Nylon + 10% rMaSp 1 dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rMaSp I 
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I 2% 50/50 rMaSp 1 /rMaSp2 rSSps adhesive: 
• 3 mL distilled water 
• 0.18 g rMaSp I 
• 0.18 g rMaSp2 
• 0.03 µI Glutaraldehyde (50% stock solution) 
• 0.1 g Bovine Serum Albumin (BSA) 
12% 50/50 rMaSp J/rMaSp2 + I% Glutaraldehyde rSSps adhesive: 
• 1 mL 12% 50/50 rMaSpl/rMaSp2 rSSps adhesive 
• 20 µI 50% glutaraldehyde stock 
Methods 
Ten samples were collected per nylon/rSSp s mat and five per control (Tegaderm and Band-Aid). Thin 
films were cut and applied to an 8 mm gage before being loaded in tensile. Testing was conducted in dry, 
humid (appro ximately 100%), and wet conditions, to mimic possible state s of wounds in patient therapy. 
The testing wa s continued until failure of the sample, with samples being pulled at 5 mm/min. 
Results 
Data were conve1ted into stress/strain curves, and various mechanic al properti es were calculated in their 
individual spheres. The se data were passed on for mean com parison via Analysis of Variance (ANOVA) , 
and individual t-Tests. Statistical analysis was performed via JMP® software. The visual outputs of 
JMP® are explained in Appendix F. 
Toughness: 
Tou ghness is an impo1tant mechanical property of the banda ging complex, as the bandage must be 
resistant to failure upon excessive stresses. Tougher skin is more durable , and therefore able to withstand 
continuous motion and manipulation by the patient. Human skin was found to have an average toughness 
of 4.9 ± 1.5 MJ/m3 (Gallagher et al.). 
The toughnes s of the variation s of SpiderSkin as compared to commercial product s is shown in Figure 19. 
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It was noted that the rSSps mat and adhesive complexes did not demonstrate toughness similar to that of 
cun-ently available products, but exhibited toughness more comparable to human skin. This result is 
mainly due to the relative rigidity of the electrospun mat. The Tegaderm and Band-Aid controls were 
capable of absorbing a considerably higher amount of energy before failure, and thus are more likely to 
withstand the patient ' s motion. In the following Connecting Letters Repo1t, the sample s are grouped by 
their statistical significance (Figure 20). 
LI. Connecting Letters Report 
Level 
BandAid Wet 
BandAid Humid 
Tegaderm Wet 
BandAid Dry 
Tegaderm Humid 
T egaderm Dry 
SS-1-Glu D1y 
SS+Glu Wet 
SSHumid 
SSWet 
SS-+Glu Humid 
SS Dry 
A 
A 
A B 
A B 
A 8 
8 
C 
C 
C 
C 
C 
C 
Mean 
195 .32290 
194.6 0469 
183.966n 
163.04293 
145.47042 
139 .53501 
39.61657 
31 .30083 
28. 88110 
15.27153 
11.59025 
4 .82244 
Figure 20. Toughne ss grouped by statistical significance. 
The mean toughness for the rSSps bandaging complex experimental groups were con siderably less than 
that of Band-Aid or Tegaderm, however they have similar toughne ss to that of human skin in all cases . 
Similar toughness to skin could potentially provide better mechanical suppo1t to a larger wound. 
Elasti c Modulus: 
The modulus of elasticity measure s the material ' s resistance to elastic deformation. A high elastic 
modulus denotes a material that is inelastic , usually in the GPa range. For a bandaging application, a very 
inelastic material would bring discomfott as the bandage would not change with the patient. A very low 
modulus of elasticity would also be undesirable, as the bandage would not provide necessary 
support/protection to the wound. Human skin was found to have an average elastic modulus of 98.97 ± 97 
MPa, a highly variable value due to the anisotropic nature of human skin as well as the differences of skin 
propetties in different areas of the body(Gallagher et al., n.d.). The elastic moduli of the rSSPs bandaging 
system and commercially-available products is shown in Figure 21. 
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The elastic moduli for the rSSps bandages were much greater than Tegaderm /Band-Aid. [n dry 
conditions, this difference was accen tuated. Comme rcial products, likely due to their water-proof nature , 
did not show much variance in wet, dry, or humid conditions. As the ny lon/ rSSps mat is semi-permeable, 
the water could be absorbed by the bandage and result in a lower modulus of elasticity more similar to the 
elastic modulu s observed in human skin. Significantly different samples are labeled in Figure 22 . 
.!l Connecting Letters Report 
Level 
SS+Glu Dry 
SSDry 
SSWet 
SS+Glu Humid 
SS Humid 
SS+Glu Wet 
BandAid Dry 
BandAid Humid 
BandAidWet 
Tegaderm Wet 
T egaderm Dry 
Tegaderm Humid 
A 
AB 
B C 
B C 
C 
C 
C 
C 
C 
C 
C 
C 
Mean 
264 .13537 
178.35313 
119 .51718 
48.30444 
25.02537 
20.16460 
4 .98768 
3.83313 
3.63242 
3.36926 
2.89122 
1.64 317 
Figure 22. Modulus of elasticity gro uped by stat istica l significance. 
Strain at failure: 
Strain at failure denotes the exte nt to which a mater ial can be deformed without failure. ln a bandaging 
application, the bandage should be able to withstand strain at failure equal to or greater than what the 
natural skin can withstand . In human skin, average stra in at failure values were found to be 25.45 ± 5.07% 
(Gallagher et al.). The strain at failure of the rSSps bandages and commercially-available product s is 
shown in Figure 23. 
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The highl y elastic nature s of Tegaderm and Band-Aid can be noted in above Figure 23. As has been 
observed previou sly, the rSSps bandage becomes more elastic in humid and wet conditions condition s. 
The samples are grouped by statistical s ignificance in Figure 24. 
Ll Connecting Letters Report 
Level 
Tegaderrn Humid 
BandAid Humid 
BandAid Wet 
T egaderm Dry 
Tegaderm Wet 
BandAid Dry 
SS Humid 
SS+Glu Wet 
SS~Glu Humid 
SS+Glu Dry 
SSWet 
SS Dr/ 
A 
8 
8 
8 
8 
C 
D 
D E 
D E F 
D E F 
E F 
F 
Mean 
727.83927 
601 .73479 
579.58 185 
575.19696 
547.14594 
472.908S4 
70.02188 
66.49676 
3s.,sno 
24 .60110 
20.68700 
9.56714 
Figure 24. Strain at Failure Grouped by Statistical Significance. 
As noted in the elastic moduli sectio n, the rSSp s bandage comp les is not as elastic at the Tegaderm and 
Band-Aid controls. The rSSps /nylon bandage s resulted in considerably lowe r strain at failure values than 
the Tegade1m or Band-Aid controls, however the values were much closer to the 25% strain typical of 
human skin . In dry conditions , spider silk underperformed the strain at failure of skin, but in a wound 
application, the bandage is more like ly to be under high moisture condtions. 
Ultimate Tensile Strength: 
Ultimate tensile strength denotes the maximum resistance to elongation exhibited by the material at any 
point before failure. The average ultimate tensile strength of human skin was found to be 27.2 ± 9.3 MPa 
(Gallagher et al.). Optimal values would mimic the natural skin, as a higher value could lead to 
discomfort when the skin is able to stretch more than the bandage, and a lower value could lead to 
bandage inefficiency. The ultimate tensile strength of the rSSp s bandaging structure and commercially-
available product s is shown in Figure 25. 
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Ultimate tensile strength was the most similar of any tested parameter. On average , rSSps formulations 
exceeded the values of both Tegadenn and Band-Aid , however , as can be seen in Figure 26 , these values 
were often insignificant. 
.:::I Connect ing Letters Report 
Level Mean 
SS+Glu Dry A 37.595118 
SS Wet B 25.081620 
SS+Glu Wet B C 22.403089 
SS Dry B C D 18.252513 
SS+Glu Humid B C D 15.664019 
SS Humld B C D 15.401418 
Tegaderm Wet B C D 13.100770 
BandAid Humid C D 11.449 892 
BandAid Wet C D 10.901183 
BandAid Dry C D 10.591657 
Tegaderm Dry D 8.904093 
Tegaderm Humid D 7.84 1741 
Figure 26. Ultimate tensile strength group ed by stati stical significance. 
The rSSps adhesive formulations were not significantly higher than Tegaderm or Band-Aid, however they 
were closer to the average ultimate tensile strength for human skin. The rSSps adhesives in wet 
environment s resulted in the closest values to that of human skin. 
Conclusion 
The rSSps adhesives, both with and without glutaraldehyde , replicated the mechanical propertie s of 
human skin closer than either commercial product, Tegaderm or Band-Aid. The toughness of both rSSps 
adhesive /mat formulations were significantly less than that of the commercial alternatives , but more 
similar to the value of human skin . The elastic moduli of the rSSps adhesive /mat formulations were 
higher than Tegaderm or Band-Aid , but again closer to human skin. The bandage failed at similar values 
to human skin, which was much lower than the strain failure value s found for Tegaderm and Band-Aid. 
The most similar property to human skin for the rSSps adhesive /mat compl ex was the ultimate tensile 
strength , in which very little statistical significance was found between groups, and most were below the 
strength of human skin. 
From the data that were collected, it was suggested that a "second skin" made from an rSSp s adhesive a 
nylon /rSSps electrospun mat could match the mechanical propet1ies of skin . In contrast to Tegaderm and 
Band-Aid , the rSSps adhesive has the potential to be loaded with growth-inducing and/or anti-microbial 
additives. An application of this loading will be demonstrated hereafter. 
H. Chlorhexidine Gluconate Release 
Rationale 
Chlorhexidine gluconate is an antimicrobial compound useful in preventing infection. This testing was to 
evaluate the chlorhexidine release when incorporated into the bandage through the rSSps adhesive. This 
simultaneously tested the strength of the interaction between adhesive and mat complex and whether the 
addition of glutaraldehyde increases this interaction. 
Decisions 
After consultation with 
biomedical companies, 
chlorhexidine was chosen as 
the most plausible option for 
this application 
Testing Methods 
Antimicrobial In electrospun 
fibers (ideal scenario) Antimicrobial in adhesive 
Spinning efforts were 
unsuccessful-needs more 
research 
Would allow for all over 
antimicrobial release in the 
wound 
Figure 27. Decision tree for chlorhexidine gluconate release. 
Chosen as the only current 
option for this project to test 
an antimicrobial release 
After the decision was made to only include the antimicrobial in the adhesive for this particular test, it 
was decided to test the mat/adhesive complex for antimicrobial release under total immersion in 
phosphate-buffered saline. These testing conditions would illustrate the fastest release possible for the 
bandaging material and allow for the best opportunity for a controlled experiment. However, a wound 
environment will have va1ying levels of moisture and the bandaging material would likely never be 
completely submerged as was done in this experiment. 
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Materials 
• UPLC Chromatographic System 
• Acquity UPLC BEH C 18 Column 
• Centrifugal Dryer 
• Phosphate-buffered saline 
• 6 well cell culture plate 
10% Nylon + 10% rMaSp 1 dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rMaSp 1 
12% 50/50 rMaSp l/ rMaSp2 rSSps adhesive: 
• 3 mL distilled water 
• 0.18 g rMaSp I 
• 0.18 g rMaSp2 
• 0.03 µI Glutaraldehyde (50% stock solution) 
12% 50/50 rMaSpl /rMaSp2 + 25% Chlorhexidine gluconate-loaded adhe sive: 
• 1 mL 24% 50/50 rMaSp l/rMaSp2 adhesive 
• 1 mL 50% chlorhe x idine stock solution 
Methods 
In this study, three sets of experimental samples (n = 2) were prepared. These three experimental sets 
were one set of nylon/rMaSp I electrospun mats with no adhesive and two sets of nylon /rMaSp 1 
electrospun mats coated with the two different adhesives: 50/50 rMaSp 1 :rMaSp2 and 50/50 
rMaSp 1 :rMaSp2 with 25% glutaraldehyde. These two sets including the rSSp s adhesive included 
chlorhexidine gluconate to a final concentration of 25%. Analysis of the relea se was completed with ultra 
perfonnance liquid chromatography (UPLC) and results were analyzed using a previou sly prepared 
standard release curve for chlorhexidine gluconate . 
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The electrospun mats and adhes ives were prepared according to the methods detailed in Appendices A 
and B. Once these samp les we re prepared, they were each placed in 5 mL of l x pho sphate buffered sa line 
in individual wells of a six -we ll ce ll culture plate. Initial I mL samp les from each we ll were taken. The 
well plate was then placed in a 3 7 °C incubator. 1 mL samples were taken from eac h we ll at 24-ho ur 
intervals for 14 days. Each day, a ll of the phosphate-buffered sa line was replaced , and the samp les were 
placed in a dry six -we ll plate wit h a fres h 5 mL of phosphate-buffered sa line. 
Results 
The ana lysis of chlor hexid ine re lease showed a release for both SpiderSkin formulat ions up to four day s. 
The rSSPs adhes ive with g lutaraldehyde exhib ited a seco ndaiy peak at about three days, indicat ing that 
the cross-li nking agent aided in the interactio n between nanofiber and rSSP s ad hesive. The release 
profiles can be see n in Figure 28. 
Chlorhexidine Gluconate Release Profiles 
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Figure 28. Ch lorhex idin e gluconate release profile from standard rSSp s mat/adhesive comp lex with no 
cross -link ing. 
Conclusion 
The ch lorhexid ine gluconate relea sed much more rapidly than expected for each of the samples. Th is may 
be due to the majority of the ch lorhexidine being aro und the bandag e instea d of intercollated in between 
the mat fibers. Becau se of this , the majority of the ch lorhexidi ne was released in the first two to three 
days and, in the case of the standard bandage with no cross -lin king, the drug was almost ent irely eluted 
from the bandage by day four (Figure 28). However, the mat /adhesive interact ion is evident in that not all 
of the antimicrobia l was immediate ly relea sed into the so luble pha se. Because the ad hesive is aqueo us, it 
is a re liab le assumpt ion that the drug remained "s tuck " in the nanofiber s through an adhesive /fibrous mat 
interaction. These interact ions seemed to be increased with the add ition of glutara ldehyde as a cross-
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linking agent. In this case , a large burst of chlorhexidine release was seen as late as day three (Figure 28). 
The glutarald ehyde also had a s light release after day five and up to day eight. 
I. Cytotoxicity Evaluation 
Rationale 
Toxicity testing of the bandage was important to the project to demonstrate the ability of SpiderSkin to 
promote healin g without causing fu1ther damage to the epidennis. Any toxic materials which are able to 
leach out of the bandage wou ld pose a threat to the healing ability of the wound . There are generally three 
types of cytotoxicity tests that were ava ilable to choose from. First, the direct contact method involves 
grow ing a culture of cells to confluen cy, placing the biomaterial on the surface and evaluating 
cytotoxicity using live/dead cell counts. Second, agar diffusion works by minimizing the influence of 
phys ical contact between cells and biomateria l. Agar is placed between the ce lls and the material and the 
leachables from the biomater ial are allowed to travel through the agar. The final method is the elution 
method. In thi s method the biomaterial is soaked in media, allowin g leachab les to travel from the 
biomaterial into the media. Thi s same med ia is then used to grow ce lls. Advantages and disadvantages of 
eac h of these meth ods are out lined in Figure 29. 
Advantages 
Disadvantages 
Direct contact 
Eliminate ext raction prepa ration 
Zone of diffu sion 
Ta rget cell con tact with material 
Mimic physiological conditions 
Standar dize amou nt of test materia l or test 
ind eter minate shapes 
Can exten d expos ure t ime hy adding fresh 
media 
Cellular tra uma if mate rial moves 
Cellular trauma with high density mater ials 
Decreased cell population with high ly solu-
ble roxicants 
Agar diffu sion 
Eliminate extrac tion preparation 
Zon e of diffusion 
Better co ncentr ation gradient of 
toxicant 
Can test one side o f a mate rial 
Independent of material density 
Use filter paper disk to test liq· 
uids or extracts 
Requ ires flat su rface 
Solubil ity o f toxicant in agar 
Risk of thermal shock when pre· 
pa ring agar overlay 
Limited exposure time 
Risk of absorbing wate r from 
aga r 
Figure 29. Description and Compari son of Cytotoxicity Testing Methods. 
Decisions 
Eluti on 
Separat e extraction from testing 
Dose response effect 
Extend expo sure time 
Choice of ext ract conditions 
Choice of solvents 
Addit iona l time and steps 
The method chosen was most similar to the elution method. Thi s method was decided upon because it 
was a quick and simple meth od to determine the cytotoxicity of leachable chemicals from the bandaging 
material. Other poss ible methods could have included animal testing models , sample submer sion cell 
culture , or chemi ca l testing of leachables into solution. The animal testing model was decided against due 
to the complexity of testing and the high varia bility and interferin g var iables . Sample submers ion cell 
cultur e was dec ided against due to lack of materials and the added complexity of the test ing mode l. 
Chemical test ing of leachables into so lution was not used because it wou ld be diffi cu lt to tie thes e results 
to cytotoxic ity in vivo. MRC-5 ce lls were used beca use they are commonly used in cytotox icity studies 
and could be obta ined from GE Healthcare Hyc lone. The design decision tree can be seen in Figure 30. 
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Testing Method 
Test all bandage 
compositions for 
cytotoxiclty 
Testing Materials 
Determine 
requirements of 
testing design 
Determine capacity 
to perform testing 
design 
Capicity to perform 
test 
-W 
Direct Contact Agar Diffusion Elution 
Figure 30. Decision tree for cytoto xicity evaluation. 
Materials 
• 8 mL screw cap tubes with a flat base 
• Nunc lon 24 we ll plate s 
• MRC-5 Lung ce lls 
• DMEM + I0¾FBS media 
• 50% glu taraldehyde in solut ion 
• Trypsin 
• ViCell 
I 0% Ny lon + 10% rMaSp I dope: 
• 3 mL Formic Acid 97% 
• 0.3 g Nylon (Rio 20# Monofilament) 
• 0.3 g rM aSpl 
12% 50/50 rMaSp l/ rMaSp2 rSSps adhesive: 
• 3 mL distilled water 
• 0.18grMaSp1 
• 0.18grMaSp2 
• 0.03 µI Glutara ldehyde (50% stock so lution) 
Cell Une {MRC-5, 
Vero) 
Media {HyColne 
Provided) 
Container (Flask, 24 
well plate) 
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o Bovine Serum Albumin (BSA) 
12% 50/50 rMaSpl /rMaSp2 + 1% Glutaraldehyde rSSps adhesive: 
• l mL 12% 50/50 rMaSpl/rMaSp2 rSSps adhesive 
• 20 µI 50% glutaraldehyde stock 
Methods 
The desired amount of electrospun mat/rSSps adhesive was weighed out using an analytical scale 
(weights within the range of l 0-30 mg). Weighed out mats were placed in petri dishes and exposed to UV 
light in a sterile hood for 20 minutes on each side. Sterilized mat was then added to 5 mL of DMEM + 
l 0% FBS media in 8 mL tubes. The tubes were then allowed to shake in an incubator for 20-24 hours, 
allowing the mats to leach into the media. The 8 mL tube s were then placed under a sterile hood and the 
mat material was removed using tweezers. The media was then run through a 22 um syringe filter to 
remove any mat pa1ticulate remaining in the media. 4 mL of each media treatme nt was then placed in a 
new 8 mL tube , and the remainder was discarded. The amo unt of inoculum required to get l 0,000 
cells/cm 2 was then calculated, and each of the 8 mL tube s was inoculated with the same volume of 
inoculum. 1 mL of this inoculated media was then placed in the 4 wells of a column of a 24 well plate. 
The plate was covered and placed in an incubator . Fresh media , which had not been exposed to any mat 
sample, was used as the negative control , while a concentration range of 50% glutaraldehyde was used as 
the positive control. The desired volume of glutaraldehyde was added to separate wells in the 24 well 
plate. 
To measure the cell growth of each media treatment , the cells were pulled into suspension using standard 
adherent cell passaging techniques . 300 µL of trypsin was used and once the cells had released 600 ~LL 
DMEM + 10% FBS was added. The cell densities were then determined on the ViCell Cell Counter. 
Results 
Initial Trial: 
The initial trial was conducted with the mats and concentrations expressed in Table 4. Each tube was 
inoculated at 5000 cells /cm 2 . As can be observed from Figure 31 there was a significant change in 
coloration of the media during the 24-hour incubation period. This phenomenon was likely due to 
contamination of the mats when they were immersed in the media. Samples were eventually discarded 
due to lack of cell growth and contamination issues. 
Table 4. Initial Trial Cytotoxicity media treatments 
Media Treatment \ Concentration 
Fresh Media (No Treatment) NIA 
Mat with SS + Glut. adhesive 10 mg 
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Mat with SS + Glut. adhesive 20 mg 
Mat with SS + Glut. adhesive 30 mg 
Mat with SS adhesive 10 mg 
Mat with SS adhes ive 20 mg 
Mat with SS adhesive 30 mg 
SS Mat with No Adhesive 40 mg 
50% Glutaraldehyde solution 10, 20, 30, 40, 100, 200, 300, and 400 ul 
(A) (B) 
(C) (D) 
Figure 31. Cytotoxicity testing . (A) media samples with treatment before incubation (B and C) media 
samp les after 24-hour incubation. (D) 24-we ll plates with post-incubation media. 
UV Trial 1: 
The initial trial was cond ucted with the mats and concentrations expressed in Table 5. Vials were 
inoculated at 10,000 cel ls/cm"'2. Prior to immersion in the media , each mat sample was sterilized using 
UV radiatio n as can be seen in Figure 32. Cell counts were taken on day 5 after inoculation and results 
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can be seen in Figure 33. It was observed that viable cell density read ings were outside the recommended 
range of the Vi Ce ll cell counte r. 
Table 5. UV trial 1 cytotoxicity media treatments 
Media Treatment Concentratio n 
Fresh Media (No Treatment) NIA 
Mat with SS + Glut. adhesive 10mg 
Mat with SS + Glut. adhesive 30 mg 
Mat with SS adhesive 10 mg 
Mat with SS adhesive 30 mg 
50% Glutaraldeh yde so lution 5, 10, 15, and 20 ul 
Figu re 32. UV techniques and setup for sample steri lization 
(A) (B) 
Figure 33. Cytotoxicity testing. (A) media samp les with treatment before incubation (B) media samples 
with treatment after 24-hour incubation. 
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UV Trial 2: 
The initial trial was conducted with the mat formulations and concentrations expressed in Table 6. Via ls 
were inoculated at 10,000 cells/cm2• Prior to immersion in the media, each mat sample was sterilized 
using UV radiation. After inoculation, the media was extruded through a 22 um syringe filter to remove 
mat particulate matter. As can be observed in Figure 34 there was once again some discoloration of the 
media indicating contamination during the incubation period . Cell counts were taken on day 6 after 
inoculati on and results can be seen in Figure 35. 
Table 6. UV trial 2 cytotoxicity media treatments 
i 
Media Treatment Concentration i 
Fresh Media (No Treatment) NIA 
Mat with SS + Glut. adhesive 10 mg 
Mat with SS + Glut. adhesive 20 mg 
Mat with SS + Glut. adhesive 30 mg 
Mat with SS adhesive 10 mg ; 
Mat with SS adhesive 20 mg 
SS Mat with No Adhesive 30 mg 
50% Glutaraldehyde so lution I, 2, 3, and 4 ul 
(A) (B) 
Figure 34. Cytotoxicity testing. (A) media samp les with treatment before incubation (B) media samples 
with treatment after 24-hour incubation. 
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Figure 35. Average Viable Cell Density under various treatments. Error bar s constructed us ing one 
standard error from the mean. 
Conclusion 
The purpose of these tests was to determine the plausibility of using these electrospun 
mat/adhesive formu lations as bandages . Bandages which leach cytotoxic by-products would not meet the 
overall design criteria of creating a non-cytotoxic bandage. As can be observed in Figure 35; all 
SpiderSkin bandages including glutara ldehyde had s ignificantl y lower viab ility . Due to these results, there 
will need to be caution and fu1ther research done for the glutaraldehyde treated bandage s. However, it is 
important to note some of the testing parameters in reference to these results. MRC-5 is a notoriously 
difficult cell line to work with. It would make the results stronger to have more replications of each 
condition grown in larger volumes. This wou ld ensure that a lack of growth was in fact due to bandage 
propertie s and not bad growth populations. That being said, it does appear very clear from the data 
obtained that glutaraldehyde -leaching caused cytotoxicity (seen in Table 7). It has been shown in the 
literature (Bhamidipati, Coselli, & LeMaire, 2012) that glutaraldehyde can be used for indwelling medical 
devices without causing a cytotoxic response. These applicati ons are made possible when the 
glutaraldehyde cross-links completely and there is no excess glutaraldehyde to cross link with unintended 
tissues . This excess glutaraldehyde was likely the cause for the cytotoxic response see n in the SpiderSkin 
bandage material. It would be beneficial to do more testing on the required concentrations of 
glutaraldehyde needed to ensure complete cross-linking, without compromis ing the biocompatibility of 
the bandaging material. 
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Table 7. Score chart for cytotoxicity assay 
rSSps + Glutera ldehyde rSSps adhes ive/rSSps+Ny lon 
adhesive/rSSps + Nylon Mat Mat 
Score ( 1-5 based on ce ll growth) I 5 
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Final Design Review 
The deci sion progress ion throu ghout this design process can be seen in Figure 36. Th e areas highli ghted 
in blue show the paths followed that led to the final product, SpiderSkin. While there are st ill many areas 
left to be explored in the design of an interactive and tunable banda ging system, the final produ ct of this 
project serve s as a prot otype. 
T-
Spider Skin 
Figure 36. Final flow diagram. Aspects incorporated into the final design have blue fill. 
The final formulation of the mat and adhesive for SpiderSkin was chosen to be the Nylon/rMaSpl and 
12% 50/50 rMaSp 1/rMaSp2, respectiv ely. This formulation resulted in similar mechanical propertie s to 
the Nylon /rMaSp 1 and 12% 50/50 rMaSp 1/rMaSp2 + 1 % Glutaraldehyde formulation , howeve r in 
cytotoxici ty testing glutaraldehyde at 1 % concentra tion was causing cyto toxicity. Without sacr ificing 
mechani cal stability , the chosen fonnulation maintain s biocompatibilit y with mammali an cells. 
In mech anical prop e11ies, the chosen formulation, deemed "S piderSkin ," is more comparable to skin than 
to Tegaderm or wate r-proof Band-Aid. While providing protecti on similar to these commercial products, 
the product is a lso able to provide suppo11 similar to that of skin for large r epith elial injurie s. 
As was expected from the biocomp at ibility propertie s of spider silk, SpiderSkin does not decrease the 
viability of ce lls. Thi s leaves room for fu11her exploration of the poss ibiliti es of SpiderSkin as a cell 
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scaffold. Antimicrobial incorporation into the adhesive produced a strong initial burst of chlorhexidine, 
however the relea se was not sustained over a desired period of seve n to ten days. 
The initial goals of this project were to create a bandaging product that could compete with existing 
bandaging product s, and add more factors to promot e wound healing. Although most of the objectives 
were achieved, the ones that were not have been noted for future work. Figure 3 7 shows the simplified 
design process, while Table 8 illustrate s the initial objectives compared to the results that this design was 
able to achieve. 
Electrospun Mat 
SpiderSkin 
rSSps Adhesive 
Figure 37. Overview of the design process for the final product. 
Tensile Testing 
Antimicrobial 
Release 
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Table 8. Comparison between initial objectives and final results. 
Initial Objectives 
Use glutaraldehyde as a cross-linking agent to 
strengthen the mechanical properties of the 
adhesive. 
Create a mat /adhesive complex with and 
without cross-linking that stretches without 
removal in cyclic flexion and compression on 
pigskin. 
Results Achieved 
In some cases, glutaraldehyde offered 
statistically significant increases in mechanical 
properties under different environmental 
conditions. However, these increases were not 
drastic. 
Under cyclic compression the rSSps and rSSps 
+ glutaraldehyde samples produced similar 
results to the Tegaderm and Band -Aid 
controls, with minimal from the pigskin. 
Under cyclic flexion, the rSSps and rSSps + 
glutaraldehyde samples had similar results to 
the Band-Aid samples, and outperformed the 
Tegaderm samples . 
The SpiderSkin adherence was not affected by 
wetness and humidity compared to the 
controls. 
Ensure that the bandage does not exibit 
cytotoxicity, with paticurlar focus 
glutaraldehyde treated bandages. 
Excess glutaraldehyde that was not cross-
linked in the SpiderSkin bandage was shown to 
be cytotoxic. 
The SpiderSkin bandage without 
glutaraldehyde did not exhibit any cytotoxicity. 
Create an rSSps antimicrobial adhesive using A release profile of chlorhexidine was created 
chlorhexidine and exhibit a release of the drug from the rSSps and rSSPs + glutaraldehyde 
over time . adhesives. The adhesive with the 
glutaraldehyde showed a slightly longer release 
profile, and a secondary peak around day 
three. 
Design a mat /a dhesive complex that adheres to SpiderSkin showed ability to maintain more 
the skin as well as or better than conventional adherence under dry wet and humid conditions 
skin adhesives. when compared to Tegaderm and Band-Aid 
controls. 
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Discussion 
Selection of Mat/rSSps Adhesive 
By doing a criteria comparison test using the criteria: ease of spinning, material availability , and the 
pressure sensitive tape test results it was possible to obtain an rSSps adhesive /mat formulation that would 
work well for this design process . Using these criteria as guidelines helped create a product that would be 
easy to work with as well as easy to test. Of course , in the future much more research can be done on 
altering these formulations to achieve a wide variety of mechanical prope1ties depending on the desired 
application /area of the body that bandaging material is needed. Nylon was not the ideal polymer to blend 
with the rSSps to make the final electrospun mat mostly due to the fact that it is not biodegradable. 
However , other polymers proved to be too hard to spin and combine with the rSSps in order to complete 
their testing. Without fu1ther investigation into the electrospinning methods using these polymers , it is not 
possible to tell whether nylon was the ideal choice for this product. However, adequate mechanical 
properties were achieved using nylon and the design objectives were met. 
T-Peel Testing 
Using the T-Peel testing method was the best way to quantify the adhesive properties of the SpiderSkin 
product. This testing method is commonly used for tissue adherence testing and allowed for a quantitative 
evaluation. The SpiderSkin adhesive without glutaraldehyde did not exhibit a decreased adherence when 
exposed to different environmental conditions like moisture and complete submersion. Although this 
adherence did not quite match the adherence of the water-proof Band-Aids , it did outperform Tegaderm 
in every environmental condition. Ft11the1more, the cross-linked rSSps adhesives exhibited a stronger 
adherence to pigskin than their counterparts especially in the dry and wet testing categories. With these 
results, it is reasonable to conclude that the cross-linking did allow for the adhesive to bond more strongly 
with the skin tissue. This finding was statistically significant, however it was not as drastic of a change as 
was expected. This could be due to the fact that the concentration of glutaraldehyde to optimize cross-
linking was not studied. There may be a better method to include this component to obtain the best 
mechanical properties possible. 
Cyclic Fatigue Testing with Bandages in Compression 
Cyclic fatigue testing was a valuable parameter for the quantification of the durability of SpiderSkin. As 
bandages are constantly being subjected to compression /extension, cyclic testing is a necessity in 
evaluating the viability of the product in real-world application. SpiderSkin matched the compression 
durability of Tegaderm and Band-Aid, and exceeded the result of Band-Aid under wet conditions. 
As SpiderSkin, Tegaderm , and Band-Aid all yielded high results, fwther testing should be conducted to 
evaluate the bandaging systems under a greater number of cyclic compressions. In this testing , 
glutaraldehyde did not seem to exhibit a significant impact on the durability of the product , although that 
impact may be observed under more extreme cyclic testing. 
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Cyclic Fatigue Testing with Bandages in Flexion 
Similar to cyclic testing in compression, cyclic flexion testing is valuable for quantifying the durability of 
the SpiderSkin. An inability to flex with the needs of the patient could cause the bandage to come off 
prematurely, increase pain , or aggravate the wound in its recovery stages. More variability was seen in 
tlexion than compression, and SpiderSkin yielded higher results than commercial products in almost 
every condition. 
Inflexion testing, glutaraldehyde seemed to decrease the durability of the bandage. This is likely due to 
an increased number of crosslinked proteins , inhibiting the ability of the bandage to stretch with the skin. 
Band-Aid s were most able to compete with SpiderSkin, and Tegad erm was the least durable. In summary, 
SpiderSkin matched or exceeded the durability of its commercial counterpa1ts in every condition. 
Tensile Testing of Materials 
Tensile testing is a valuable metric for describing the mechanical prope1ties of the bandage itself. As 
previous T-Peel and fatigue tests are valuable for comparing the adhesive propertie s of the bandage , 
tensile testing describes the entire bandaging system, encompassing both the mat and adhesive. Individual 
parameters will be discusse d in their respective spheres, followed by an integrative discu ssion of the 
prope1ties and their implications to the product as a whole. 
Toughness 
SpiderSkin was considerably less tough than Tegaderm and Band-Aid. This phenomenon will be 
explained further in subsequent parameters obtained via tensile tests, however , the lower resultant values 
for toughnes s are due to the rigidity of the SpiderSkin bandage relative to the elastic natures of both 
Tegaderm and Band-Aid. 
Elastic Modulus 
SpiderSkin had a much higher elastic modulu s than Tegaderm and Band-Aid. Higher values of elastic 
moduli indicate that greater pressure must be exe1ted before defonnation in the product will occur. As 
was expected , the d1y condition resulted in higher elastic moduli than in wet/humid condition s, as water 
permeating the bandage allows the bandage to relax and become more elastic. 
SpiderSkin more closely mimicked the elastic modulu s of human skin than did either commercial 
product. This can be advantageous as the body seeks to repair the wound. Beyond providing protection 
for the wound, spidersilk can give suppo11 similar to that of skin. As underlying repair mechanisms and 
newly formed ti ssue are ve1y delicate and sensitive to mechanical perturbations , the relative inelasticity of 
SpiderSkin can prevent excessive stress from disturbing sensitive tissue. 
Strain 
Tegaderm and Band-Aid were much more elastic than SpiderSkin. Although a higher elasticity would be 
preferable if the elastic modulu s and were able to be maintained , SpiderSkin resulted in similar/higher 
values of strain as compared to human skin. Whereas Tegaderm and Band-Aid stretch to many times their 
original size, Spiderskin averaged about 1.5 times its original length . 
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Ultimate Tensile Strength 
As is often correlated with a higher modulu s of elasticity, SpiderSkin resulted in higher ultimate tensile 
strength values than did Tegaderm or Band-Aid. As was discussed previously, this can be advantageous 
for providing support to underlying tissue as it is very sensitive during the repair proce ss. Once again, 
SpiderSkin more closely mimicked the properties of human sk in as compared to the commercial products 
Tegaderm and Band-Aid. 
Integrative Discussion 
Spiderskin has favorable mechanical prope11ies for use in severe epithelial injury. While providing needed 
protection , having similar stre ngth and elasticity allows the bandage to provide suppo11 beyond what 
commercial products provide. Thus, instead of mechanical stresses being applied to delicate tissue, the 
perturbations will be dispersed along the bandage and app lied to healthy surrounding tissue. 
Chlorhexidine Release 
The ability of this bandaging product to be functional and promote healing is integral to the design 
product and it creates the possibility to set this product apa11 from other products on the market. Using 
chlorhexidine in the rSSp s adhesive instead of incorporating it into the electrospun mat fibers was not 
ideal, howe ver with further research it is proposed that this would be plausible in the future by altering the 
concentration of chlorhexidine in the electrospinning dope. Without this antimicrobial in the fibers, a 
longer and susta ined release was not expected, however in this scenario it was possib le to test the physical 
entanglement interaction between the rSSps adhesive and the electrospun mat nanofibers. Because the 
rSSps is aqueous, much of it was expec ted to release early, however the addition of glutaraldhyde allowed 
for more chlorehexidine gluconate to stay in the bandage upon submers ion. This is evident by the high 
amount of mass released as late as day 3 (Figure 29). This level of mass release is comparable to the same 
amount that was released almost immediately upon submers ion from the standard bandage. Even without 
the gluataraldehyde, how ever, it is evident that the physical entanglement of the rSSps adhesive /fibrou s 
mat complex can hold in at least some of the antimicrobial. As you can see in Figure 28, even the 
stan dard bandage had a slight release of antimicrobial as late as day 4 submerged in phosphate-buffered 
saline. With these result s in mind, it has to be noted that it would be rare in real-life application for this 
"second skin" material to be fully submerged for long amounts of time. Therefore, these results represent 
the fastest release possible. It is probabl y that the release may be more sustain ed over longer periods of 
time in conditions that have varying levels of moisture. For fu11her research , it may be most beneficial to 
create this product with an antimicrobial both in the rSSps adhesive and in the fibers of the electrospun 
mat. Of course, the different concentrations of antimicrobial in the complex may need to be tuned for 
optimal effectiveness. 
Cytotoxicity testing 
The biocompatibility of the bandage is significant as it will be applied to compromised tissue. The focus 
of the cytotoxicity tests was to determine initial toxicity of spider si lk banda ge with spider silk based 
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adhesive and the effect of the addition of the cross-linking agent glutaraldehyde. The tests showed that the 
addition of glutaraldehyde to the adhesive did cause cytotoxicity. It is hypothesized that this was due to 
excess glutaraldehyde in our adhesive formulation which was not crosslinked. This non-crosslinked 
glutaraldehyde was free to interact with the cells and cause cell death or inhibit cell growth. Due to this 
finding, our final design product will be created without the addition of glutaraldehyde. The mechanical 
properties of the rssp's adhesive were satisfiability close to those of skin to accomplish our initial design 
criteria without the need for a crosslinking agent. It was, however, observed that the addition of the 
glutaraldehyde adhesive improved the release profile for chlorohexidine. It is recommended that further 
studies be done to determine the correct concentration of glutaraldehyde which will prevent cytotoxicity 
but still allow for crosslinking benefits. It has been shown in the literature (Bhamidipati, Coselli , & 
LeMaire, 2012) that glutaraldehyde can be used for indwelling medical devices without causing a 
cytotoxic response . Cell adherence studies would also be wo1thwhile to show bandage benefit to tissue 
regrowth. 
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Conclusions 
Through an intensive design process , a prototype of the final product has been created. The final 
bandaging system has been ca lled SpiderSkin. 
Tensile testing results showed that SpiderSkin has mechanical properties more similar to human skin than 
commercial bandaging products such as Tegaderm Tape and water-pro of Band-Aids. Further mechanical 
testing of the adhesive showed the ability of the adhesive (compared to the Tegaderm and Band-Aid 
controls) to stay on the skin as it underwent cyclic fatigue under wet, humid and dry conditions. Thus , 
while providing superficial protection sim ilar to a bandage , SpiderSk in can also provide mechanical 
suppo1t to injuries in variab le conditions. Fu1thermore , SpiderSkin has the potential to be loaded with 
antim icrobial s and/or growth factors to fu1ther protect a wound and encoura ge healing. 
Although the design objectives were achieved within the scope of this project, this design was only able 
to cover the initial investigation into an exciting new product. Further research shou ld be considered to 
continue impro v ing the SpiderSkin bandaging syste m. The following is a list of potential branches for 
fu1ther research and these areas are detailed in the next section: 
• The concentration of glutara ldehyde and other cross-linking investigations shou ld be studied to 
prevent cytotoxicity 
• Incorporate antimicrobial into electrosp un mat nanofiber s to prolong the antimicrobial release 
• Incorporation of growt h factors 
• Comb inati on of rSSps with other biodegradable polymers to impro ve mechanical properties 
• Testing of cell adhesion to electrospun mat as potential app lication for a cell scaffo ld 
Recommendations for Future Work 
Alternate Polymers/Mat Formulations 
Due to the time constraints of this project, it was not possible to explore all of the different polymer/mat 
formulations that could be used to create this bandaging product. Nylon was the main polymer chosen for 
testing due to its availability to us and the previous research on electrospinning with recombinant spide r 
silk that had already been done with nylon. However , we believe that using a degradable polymer may be 
best for spec ific applications. The use of alternate polymers would require much more research on their 
use in electrospinning and how they may integrate with recombinant spider silk proteins. Fo1tunately, 
much research is currently being done on the production of biodegradable polymers , both synthetic and 
natural. Possible choices of synthetic biodegradable polymers include starch -based polymer blends and 
polylactic acid blends , wh ile natural biodegradable polymers includ e cellulose and soy proteins. 
Furthermore, it may be possible to create a product made of on ly recombinant spider silk protein , since 
this can be tuned for degradability, however pure spider si lk is hard to electrospin and more research 
would need to be done to produce a purely rSSps electrospun mat. Films , foams , and gels made of 
recombinant spider silk protein may turn out to be better for some of the bandaging and drug delivery 
applications as well. 
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Alternate Antimicrobial Constituents 
Chlorhexidine was the antimicrobial chosen due to recommendations from health care professionals and 
biomedical companies. Antibiotics are not a good choice for this product because of the high risk of super 
bugs and antibiotic resistant infections occurring. However , electrospinning using zinc oxide 
nanoparticles or silver may be good alternatives to an antimicrobial like chlorhexidine. From the results 
we obtained , it seems that to have a sustained release of an antimicrobial, it would be best if the fibers 
themselves contained the antimicrobial constituent within them, instead of trying to incorporate the 
antimicrobial within the adhesive. Again , this would depend on the desired application /type of injury. 
Cell Attachment / Capability as a Scaffold for Epidermal Recovery 
Preliminary research has shown that rSSps materials have potential for cell scaffolding and cell 
attachment. With fu11her research, it may be possible to incorporate epithelial cells onto the surface of the 
fibrous bandage. This would allow for a porous , integrative structure for cell growth and attachment. As 
this is applied to the skin, it may be possible to encourage epidermal recovery. 
Cross-linking 
In this study , glutaraldehyde was used as the cross-linking agent due to the fact that it is commonly used 
as a tissue cross-linking agent. However , excess glutaraldehyde is a proven cytotoxin. Further research 
needs to be done to deactivate the remaining uncross-linked glutaraldehyde or to find the exact 
glutaraldehyde concentration needed to maximize cross-linking , while having very little excess at the end 
of the process causing toxicity. 
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Identify the problem 
Gather information 
Develop possible 
solutions 
Analyze and select a 
solution 
Test and evaluate the 
solution 
Finalize project 
Timetable 
To create a spider silk bandage to 
~ used in conjunction with a 
spray on adhesive, for the 
treatment of pressure wounds 
Research existing bandage types and 
the problems they can aiu .se 
Re.sHrch properties of each type of 
biomaterial to be used 
Brain storm and test ideas for 
concentration of spider silk and 
additives, such as antimicrobials 
Compare solutions to criteria and 
evaluate to choose the best ones 
Test solutions and change as 
needed 
Finalize details 
Make poster and presentation 
Figure 38. Timetable for completion of this project. 
Background, Literature Review, Project Aims and Objectives 
Personnel: All members 
Completed: March 2016 
Pressure-sen sitive Tape Test 
Personnel: Ana Laura Licon , Danielle Gaztambide 
Completed: May 19, 2016 
3 months 
3 months 
lmonth 
4months 
1 month 
60 
SEM Imaging of Electrospun Mat/ Adhesive Formulations 
Personnel: Danielle Gaztambide, Ana Laura Licon, Thomas Harris 
Completed: May 2016 
T-Peel Adhesion Test On Pigskin 
Personnel: Danielle Gaztambide, Ana Laura Licon, Sam Briggs 
Completed: Trial I-May 2016 and Trial 2-July 2016 
Electrospun Mat/ Adhesive Tensile Testing 
Personnel: Danielle Gaztambide, Sam Briggs, Ana Laura Licon 
Completed: July 2016 
Fatigue Testing On Pigskin and Analysis 
Personnel: Danielle Gaztambide, Ana Laura Licon, Michael Paskett 
Completed: End of July 2016 
Chlorhexidine Elution and Analysis 
Personnel: Danielle Gaztambide, Thomas Harris 
Completed: November 2016 
Cyclic Stretching Test on Pigskin 
Personnel: Danielle Gaztambide , Ana Laura Licon 
Completed: October 2016 
Analysis of Tensile Testing Data and Statistical Analysis 
Personnel: Michael Paskett 
Completed: October 2016 
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Analysis ofT-Pee l Data 
Personne l: Ana Laura Licon, Michael Paskett 
Completed: October 20 16 
Toxicity Testing 
Personnel: Sam Briggs, Ana Laura Licon, and Danielle Gaztambide 
Completed: October 20 16 
Analysis of Tox icity Testing 
Personnel: Sam Briggs 
Comp leted: October 2016 
Statistical Analysis on a ll Other Tests 
Perso nnel: Michael Paskett 
Completed: October 2016 
Write-Up and Final Repo1i/Poster 
Personnel: Sam Briggs , Danielle Gaztamb ide, Ana Laura Licon, and Michael Paskett 
Complet ed: December 2016 
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Reflective Writing 
For my senior capstone project , I have been working in Dr . Randy Lewis Spider Silk Laboratory, 
designing a "seco nd skin" from recombinant spider silk protein s. With a group of four undergraduate s we 
have worked this project from conceptualization stages to a final product. Through this project, I have 
learned about the complete spectrum of research and design. It has been a valuable project and the related 
experience will benefit me greatly as I pursue graduate education. 
Our project began with a brain storm. As our group was working in the Spider Silk Laboratory, we 
had many potential applications to choose from . After hearing the experience of a postdoc toral fellow at a 
conference, we realized that there is a big market for bed sore/bum victims. We started to hypothesi ze 
different method s of formulating our bandage and adhesive, and drew up a proposal which was later 
approved by the department. 
We produced several formulations for the mat for our bandage and performed mechanical testing 
on the mat to ensure we had the prope1ties we needed in a bandage. After making a decision on which 
formulation of mat to use in the final product , we moved on to adhesive formulations. 
Similar to choosing a mat formulation, we tested out severa l spider silk adhesives to use with our 
mat. We performed several tests on the adhesive in combination with the chosen mat. We harvested pig 
skin, and te sted the formulation's adhesion to pig skin. Pig skin gave us a good representation of how the 
product would perform in vivo. 
After the selection of a mat and adhesive, we began testing an antimicrobial compound, 
chlorhexidine , and its ability to prevent bacterial growth when incorp orated into the bandage. Through 
our testing we found that there was no growth, however the inhibition was likely due to our antimicrobial 
and an additive in the adhesive. Finally, we evaluated our product's biocompatibility by growing 
mammalian cells in the presence of our bandage . 
Overall, my experience in the spider silk laboratory has been very good. I have been able to learn much 
more about the research process. I have been able to interact with very intelligent people who have given 
me great advice for pursuing my goals in both the academic and professional world. I have been exposed 
to many different thinking and working styles and those have influenced my own personal sty les of work 
and thinking. 
My experience with this senior capstone project will benefit me greatly. I have gained a much deeper 
foundation for the research process. I have learned better how to work with groups and manage dates and 
deadline s. As I am soon to begin research in a graduate setting , my background from the capstone project 
adds a major experience component that will be unlike many peer s. 
My time in Dr. Lewis' Spider Silk Lab has been a great experience for multiple reasons. I have been able 
to understand and apply practical information about proteins and purification better. As I have increased 
my scientific understanding of what goes on in the laboratory , I have also become more familiar with the 
managerial aspects of laboratory work. I am excited to continue my work in the laboratory. 
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As a mentor , Dr. Lewis has been very helpfu l. He has been hands-off, allowing us to perform the resea rch 
in our own way, while providing va luab le input and feedback whenever we need it. Our relationship is 
very similar to wha t I wi ll look for in a grad uate sett ing as we ll. I couldn't really say that there were any 
d iffic u I ties. 
Lastly, I wa nt to share some advice I have for future capstone proje cts: 
1. Realize the impo1tance of yo ur team. 
2. Don't bite off more than yo u can chew . 
3. Utilize resources within and without the laboratory. 
1. Your team w ill (hopefully) become your best fr iends for the duration of the project. You wi ll spend 
more time thinking about your project and working on that than you want to. The impo1tance of tru st and 
hard work from all membe rs is critical to your success . I was lucky to have honest, hard-w orking 
teammates who didn't put off any work that needed done. With that trust for eac h other, we were ab le to 
complet e a large amount of testing in a relatively shmt amount of time . It is more impo1tant to like yo ur 
team than the research you wi ll be conducting. Research, by nature and of necessity, can be repetiti ve and 
get boring. There will be times when none of you want to pe1form testing , data ana lys is, literature-
searc hes, writin g, and the wide array ofresponsi bil ities with taking on a senior project. If you and your 
team get along we ll, people won' t be shirkin g duties out of laziness. It is impo1tant to have a team with a 
variety of sk ills. Although we had all worke d in the same lab, each membe r brought specific skillsets and 
knowledge that were absolutely neces sary to comp leting a project from such diverse concepts. In 
summary, don't choose a project and then a team. Choose a team and then a project. Reversing the 
chronology of these events can cau se problems down the road. 
2. I don' t know exactly what other majors are like, but for Biological Engineering we had about 3 
semesters to formu late, carry out, and repo1t on a project. It seems like a lot of time. We had a lot of 
ideas. That time proved to be far insuffic ient for the number of ideas we had. Realize that on top of your 
proj ect, yo u are st ill going to have class, homewo rk, work, and (if yo u really budget yo ur time) some 
form of a socia l life. Decide ear ly what the fundamental needs are for your project and finish those. If you 
have any extra tim e, pursue some of the addi tional ideas yo ur team has had along the way. Don ' t get 
distracted along the way and forget about your fundamental requir ements. We had lots of ideas. Some of 
which we began to pursue before it was appropri ate. Don ' t make the same mistake we did. It' s very easy 
to overlook the additi ona l work beyond the pursuit of the ideas . We didn ' t think abo ut finding more 
literatur e, analyzing data , and writing when we began to pursue some of our little ideas . 
3. Think criticall y about the resources yo u have and use them . You are sti ll a student. This is a learn ing 
project. You are n't expected to begin as an expe 1t on every method yo u encounter. You probab ly don't 
even know some of the methods exist which cou ld be very beneficial to eva luating your product. You 
have graduate students as an easy resource. If they don' t know , reach out to post-doctoral researchers. 
Your principal investigator will know if they don't. If within yo ur lab you don't have enough of those 
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resources, look to other labs. The research community is a pretty friendly one. Don ' t be afraid to reach 
out to another profes sor's lab. If you read a paper and want some more information about it, contact the 
author. You' II be surprised how nice people actua lly are, even if they don ' t know you. 
I hope this helps some of you on your endeavor. Senior design projects are a lot of work, but it's 
experience that can really he lp you to stand out as a student if you do it the right way. Good luck! 
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Appendix A: Mat Formulations 
Electrospun mats were used as the base for the scaffold complex made. Three different initial mat 
formulations tested: 20% nylon , 10% nylon 10% rMaSpl, and 10% nylon 10% 80/20 rMaSpl /rMaSp2 , 
all of which were disso lved in formic acid. To make the 20% nylon solution 0.6 g of nylon were placed in 
a glass vial with 3 .04 mL of 97% formic acid. To make the nylon rMaSp l/rMaSp2 so lution 0.3 g of 
nylon, 0.24 g rMaSpl and 0.06 g of rMaSp2 were added to a glass vial with 3.04 mL of97% formic acid. 
To make the nylon rMaSpl mats 0.3 g of nylon and 0.3 g of were added to a glass vial with 3.04 mL of 
97% formic acid. As each solution was made, it was left on an end-over-end plate mixer plate overnight 
for the and nylon to dissolve into a homogenou s solution. 
Each polymer solution was placed into 1 mL syringes fitted with a 0.5 inch 27-gauge flat tip disposable 
needle . To make a mat a needle filled with one of the solution s was placed into the electrospinner. The 
electrospinner was set to an extrusion rate between 0.25-0.3 mL/h and the voltage kept between 24-29 
kV. The drum was wrapped with a sheet of nonstick aluminum foil and set to rotate at 1000 rpm. The 
positive wire on the electrospinner was attached to the syringe and the rotating drum was connected to the 
negative wire. Each mat was spun for about 3.5 hours until the solution in the syringe had been used, and 
a compl ete mat had been formed. 
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Appendix B: Adhesive Formulations 
Three different adhesives were initially tested on the electrospun mats: a 12% 50/50 rMaSp l/rMaSp2 
adhesive , a 12% 50/50 rMaSp l/rMaSp2 with 1 % glutaraldehyde, and a 12% 50/50 rMaSp I /rMaSp2 with 
I 0% bovine serum albumin (BSA) and 1 % glutaraldehyde. 
To make the 12% 50/50 rMaSpl /rMaSp2 adhesive 0.18 g ofrMaSpl and 0.18 g ofrMaSp2, and 3 mL of 
distilled water were added to a small glass vial with a screw on lid. A sonicator was used with a microtip 
to create vibrations to break down the larger rSSp agglomerates , and increa se protein solubilization. The 
vial was microwaved in 3-second interval s until it reached 250°C and the protein was completely 
di sso lved. The 12% 50/50 rMaSp 1 /rMaSp2 with 1 % glutaraldehyde was made in the same way as the 
12% 50/ 50 rMaSp 1 /rMaSp2 adhesive, but 0.02 mL of a 50% glutaraldehyde stock was added per I mL of 
the rSSps adhesive to make it a l % glutaraldehyde solution. The 12% 50/50 rMaSpl / rMaSp2 with 10% 
BSA and l % glutaraldehyde was mad e in the same way as the 12% 50/50 rMaSp l/rMaSp2 adhesive, with 
an additional 0.02 mL of a 50% glutaraldehyde stock per mL of the rSSps adhesive and 0.3 g of BSA. 
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Appendix C: Pigskin Cleaning 
Pigskin was used to set the mat/adhesive formulation s for all of the tests except the toxicity assay. Strips 
of fresh pigskin were acquired from the Utah State Univer sity South Farm. Hair clippers were used to 
remove the bulk of the hair and then disposable razors were used to remove the final hair left after 
clipping . The skin was washed in baths of 30% isopropyl alcohol and water, cut into smaller pieces, 
sealed into bags, and kept in a 4°C refrigerator to keep the skin fresh for as long as possible 
(approximately 3 weeks). The skin was cut into smaller pieces as necessary for each test. 
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Appendix D. Conditions Created for Mechanical Testing 
Thre e different conditions were chosen for all of the mechani cal testing: dry , wet, and humid . The dry 
sample s were te sted as they were on the pigskin after the adhesive had dried . The wet sample s were 
submerged in water for 1 minute , dried with a paper towel and tested immediatel y . The humid samp les 
were tested under 100% humidity conditions by using a humidifier attached to a plexiglass box with a 
hose to saturate that space with water vapor. The humidity set up can be seen in Figure 39: 
Figure 39. Setup for humidity testing 
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Appendix E. Recombinant Spider Silk Proteins Used 
All of the rSSp s used in this experiment were derived from the milk of transgenic goats. The sequences of 
the two proteins used are shown below. 
rMaSpl: 
(QGAGAAAAAAGGAGQGGYGGLGGQGAGQGGYGGLGGQGAGQGA 
GAAAAAAAGGAGQGGYGGLGSQGAGRGGQGAGAAAAAAGGAGQG 
GYGGLGSQGAGRGGLGGQGAGAAAAAAAGGAGQGGYGGLGNQGA 
GRGGQGAAAAAAGGAGQGGYGGLGSQGAGRGGLGGQGAGAAAAA 
AGGAGQGGYGGLGGQGAGQGGYGGLGSQGAGRGGLGGQGAGAA 
AAAAAGGAGQGGLGGQGAGQGAGASAAAAGGAGQGGYGGLGSQG 
AGRGGEGAGAAAAAAGGAGQGGYGGLGGQGAGQGGYGGLGSQGA 
GRGGLGGQGAGAAAAGGAGQGGLGGQGAGQGAGAAAAAAGGAG 
QGGYGGLGSQGAGRGGLGGQGAGAVAAAAAGGAGQGGYGGLGSQ 
GAGRGGQGAGAAAAAAGGAGQRGYGGLGNQGAGRGGLGGQGAG 
AAAAAAAGGAGQGGYGGLGNQGAGRGGQGAAAAAGGAGQGGYG 
GLGSQGAGRGGQGAGAAAAAAVGAGQEGIRGQGAGQGGYGGLGS 
QGSGRGGLGGQGAGAAAAAAGGAGQGGLGGQGAGQGAGAAAAAA 
GGVRQGGYGGLGSQGAGRGGQGAGAAAAAAGGAGQGGYGGLGG 
QGVGRGGLGGQGAGAAAAGGAGQGGYGGVGSGASAASAAASRLSS 
PQASSRLSSA VSNLVATGPTNSAALSSTISNVVSQIGASNPGLSGCDVLI 
QALLEVVSALIQILGSSSIGQVNYGSAGQATQIVGQSVYQALG) 
rMaSp2: 
(PGGYGPGQQGPGGYGPGQQGPSGPGSAAAAAAAAAAGPGGYGPGQQG 
PGGYGPGQQGPGRYGPGQQGPSGPGSAAAAAAGSGQQGPGGYGPRQQG 
PGGYGQGQQGPSGPGSAAAASAAASAESGQQGPGGYGPGQQGPGGYGP 
GQQGPGGYGPGQQGPSGPGSAAAAAAAASGPGQQGPGGYGPGQQGPGG 
YGPGQQGPSGPGSAAAAAAAASGPGQQGPGGYGPGQQGPGGYGPGQQG 
LSGPGSAAAAAAAGPGQQGPGGYGPGQQGPSGPGSAAAAAAAAAGPGG 
YGPGQQGPGGYGPGQQGPSGAGSAAAAAAAGPGQQGLGGYGPGQQGP 
GGYGPGQQGPGGYGPGSASAAAAAAGPGQQGPGGYGPGQQGPSGPGSA 
SAAAAAAAAGPGGYGPGQQGPGGYAPGQQGPSGPGSASAAAAAAAAGP 
GGYGPGQQGPGGYAPGQQGPSGPGSAAAAAAAAAGPGGYGPAQQGPSG 
PGIAASAASAGPGGYGPAQQGPAGYGPGSAVAASAGAGSAGYGPGSQAS 
AAASRLASPDSGARVASAVSNLVSSGPTSSAALSSVISNAVSQIGASNPGL 
SGCDVLIQALLEIVSACVTILSSSSIGQVNYGAASQF A VVGQSVLSAF) 
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Appendix F. Understanding JMP® visual outputs 
From the JMP® Tutorial: 
Categorical plots: 
25-,----------------------~ 
20 -
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0 0 
a 
0 
0 
d 
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0 
A black dot represents an individual datum point. In the green diamond , the center line represent s the 
mean of the data. The top and bottom points represent upper and lower confidence points of each group. 
The lines that s lice the top and bottom of the diamond s are called overlap marks . If there is horizontal 
separation between the top overlap of one group and the bottom overlap of another, the means of those 
two groups could be significantly different. Group 'f appears to be different than group 'a' and 'd' in this 
example. 
Connecting Letters Report: 
L.l Connecting letters Report 
Level 
f A 
d B 
a B 
Mean 
16.285714 
8.000000 
7.142857 
The letter table lists the group mean s with letters to the right of them. Mean s that have the same letter are 
not s ignificantly different. Those with different letters are different. Groups 'd' and a' are both denoted 
with the letter 'B' -- they are not different. Group 'f has the letter 'A', different than both 'd' and 'a'. 
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